Tubulo-interstitial nephritis, not specified as acute or chronic

N14_TUBULOINTNEPHRNAS

pyelonephritis: Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N12 Hospital discharge: ICD-9 — 5909 Hospital discharge: ICD-8 — 5909 Cause of death: ICD-10 — N12 Cause of death: ICD-9 — 5909 Cause of death: ICD-8 — 5909 2 out of 7 registries used, show all original rules.	2954
4. Check minimum number of events None	2954
5. Include endpoints None	2954
6. Filter based on genotype QC (FinnGen only)	2954

Control definitions (FinnGen only)

Control exclude: N14_RENALTUB

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N10-N16
Name in latin: Nephritis tubulo-interstitialis sine specificatione utrum acuta an chronica

NAME	N14_TUBULOINTNEPHRNAS
CONTROL_EXCLUDE	N14_RENALTUB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N12
HD_ICD_9	5909
HD_ICD_8	5909
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N12
COD_ICD_9	5909
COD_ICD_8	5909
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Tubulo-interstitial nephritis, not specified as acute or chronic based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	33191	21919	11009
Only index persons	27247	18160	9087
Unadjusted period prevalence (%)
Whole population	0.52	0.63	0.31
Only index persons	0.56	0.67	0.35
Median age at first event (years)
Whole population	68.81	67.71	70.98
Only index persons	67.30	65.80	70.28

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2954	1835	1119
Unadjusted period prevalence (%)	0.58	0.63	0.49
Median age at first event (years)	56.93	49.17	69.66

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2680: Matched controls
26800

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

4820.9

323.0

2122

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

112.1

323.0

1337

235

59099

ICD-8 Finland

Infections of kidney, Other

+∞

323.0

349

J01MA02

ATC

ciprofloxacin; systemic

5.7

323.0

1719

6387

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

5.9

260.2

865

2016

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

25.3

199.9

286

126

59098

ICD-8 Finland

Infections of kidney, Alia definita

+∞

193.1

183

J01EA01

ATC

trimethoprim; systemic

3.6

185.1

1123

4447

N17.9

ICD-10 Finland

Acute renal failure, unspecified

230.9

169.3

173

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

16.9

169.0

277

181

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.4

162.1

546

1212

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

10.7

161.7

328

344

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

736.3

143.3

140

N30.0

ICD-10 Finland

Acute cystitis

4.0

139.5

646

1953

UKC02

NOMESCO Finland

Cystoscopy

3.8

133.9

671

2164

J01MA12

ATC

levofloxacin; systemic

3.5

128.8

733

2610

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

97.6

118.2

130

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

62.7

117.4

137

N18.8

ICD-10 Finland

Other chronic renal failure

45.6

115.9

143

J01CA08

ATC

pivmecillinam; oral

2.5

105.6

1332

7639

R50.9

ICD-10 Finland

Fever, unspecified

3.6

103.3

547

1802

A11CC03

ATC

alfacalcidol; systemic

24.0

93.7

135

C03CA01

ATC

furosemide; systemic

2.5

93.6

1046

5515

R33

ICD-10 Finland

Retention of urine

4.6

92.9

352

852

J01DB01

ATC

cefalexin; oral

2.7

92.8

2210

17053

204

Kela drug reimbursment

Leukemia lymphatica

7.3

92.6

234

346

N18.0

ICD-10 Finland

End-stage renal disease

+∞

84.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

84.4

850

4184

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

80.4

459

1574

59010

ICD-8 Finland

Infections of kidney, Pyelonephritis

+∞

79.6

TK800

NOMESCO Finland

Hemodialysis

35.6

79.5

103

A41.9

ICD-10 Finland

Sepsis, unspecified

7.5

77.0

190

270

KA1AE

NOMESCO Finland

Kidney ultrasound examination

12.9

76.6

139

113

Z49.1

ICD-10 Finland

Extracorporeal dialysis

203.3

76.6

U70

ICPC

Pyelonephritis/pyelitis

22.9

74.1

108

A12AA04

ATC

calcium carbonate; oral

30.8

73.0

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.8

73.0

570

2396

J01MA06

ATC

norfloxacin; oral

2.9

70.7

510

2037

Z94.0

ICD-10 Finland

Kidney transplant status

69.4

70.7

R31

ICD-10 Finland

Unspecified haematuria

3.5

70.6

371

1187

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

67.8

1184

7372

N30.9

ICD-10 Finland

Cystitis, unspecified

4.3

67.6

270

680

Z49.0

ICD-10 Finland

Preparatory care for dialysis

+∞

66.9

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

65.5

547

2376

N19

ICD-10 Finland

Unspecified kidney failure

10.8

65.3

129

125

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

47.8

64.9

XKD00

NOMESCO Finland

Uroflowmetry

2.7

64.1

501

2091

127

Kela drug reimbursment

Transplant complication

28.3

62.1

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

155.9

58.1

137

Kela drug reimbursment

Uraemia requiring dialysis

153.3

57.1

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

56.0

603

2970

N02BE01

ATC

paracetamol; systemic, rectal

2.2

55.9

2249

18784

A41.8

ICD-10 Finland

Other specified sepsis

11.7

55.6

105

B03XA02

ATC

darbepoetin alfa; parenteral

18.6

54.7

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.7

54.7

260

761

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

52.2

445

1930

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

84.7

52.1

SPAT1255

SPAT

Intravenous administration of medicine

3.8

51.9

239

680

R53

ICD-10 Finland

Malaise and fatigue

2.2

51.6

648

3409

L04AA06

ATC

mycophenolic acid; systemic

15.6

51.3

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

48.7

51.3

N02AA05

ATC

oxycodone; systemic

2.4

49.8

467

2130

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

48.6

958

6021

TKC20

NOMESCO Finland

Catheterisation of bladder

3.3

47.7

261

850

N02AX02

ATC

tramadol; systemic, rectal

1.8

46.7

1113

7449

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

465.5

46.4

SPAT1262

SPAT

Handing over of treatment supplies

2.3

46.3

511

2520

B05DA

ATC

Isotonic solutions

162.8

45.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

45.5

194

515

Z49.2

ICD-10 Finland

Other dialysis

444.8

44.3

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.6

44.0

369

1576

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

43.0

649

3651

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

95.7

42.9

A10AE04

ATC

insulin glargine; parenteral

2.9

42.7

277

1012

U71

ICPC

Cystitis/urinary infection other

3.4

42.0

219

686

C07AB07

ATC

bisoprolol; oral

1.8

41.9

1267

9054

5901A

ICD-9 Finland

Infections of kidney, Acute pyelonephritis

+∞

40.7

A02BC02

ATC

pantoprazole; systemic

1.7

40.7

1649

12835

A06AD11

ATC

lactulose; oral

2.1

40.4

504

2608

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

10.1

40.2

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

7.9

40.2

123

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

66.7

40.1

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.7

40.0

187

537

SPAT1167

SPAT

Insertion of urinary catheter

4.7

39.9

140

308

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

39.5

1241

8914

V03AE01

ATC

polystyrene sulfonate; oral

17.0

39.4

ZX120

NOMESCO Finland

Intravenous

2.7

39.4

290

1146

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

39.3

758

4649

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

39.3

405

1918

AA1AD

NOMESCO Finland

CT of head and brain

1.9

39.2

660

3851

G04CA02

ATC

tamsulosin; oral

2.0

39.2

611

3463

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

39.2

711

4267

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.9

38.8

166

442

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

+∞

38.6

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

197.7

37.9

B05DB

ATC

Hypertonic solutions

135.3

37.8

I50.9

ICD-10 Finland

Heart failure, unspecified

2.2

37.7

447

2257

N13.0

ICD-10 Finland

Hydronephrosis with ureteropelvic junction obstruction

+∞

37.6

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.4

37.5

117

226

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

37.2

830

5330

A46

ICD-10 Finland

Erysipelas

2.3

37.1

396

1905

A03

ICPC

Fever

2.2

37.0

413

2026

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

36.7

308

1310

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

36.5

394

1904

SPAT1263

SPAT

Sampling

1.7

36.1

1105

7806

SPAT1254

SPAT

Administration of medicine

2.1

36.1

440

2243

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.7

35.9

258

1003

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

35.8

257

998

A28

ICPC

Limited function/disability NOS

2.1

35.6

461

2409

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.0

35.6

223

794

196

Kela drug reimbursment

Paricalcitol and cinacalcet

+∞

35.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

35.2

478

2551

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.2

34.4

158

U07

ICPC

Urine symptom/complaint other

3.3

34.3

185

594

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

93.8

33.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

33.8

744

4724

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.6

33.5

273

1139

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

33.1

570

3325

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.8

32.9

148

411

N17.8

ICD-10 Finland

Other acute renal failure

331.0

32.9

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

32.9

213

775

N13.9

ICD-10 Finland

Obstructive and reflux uropathy, unspecified

172.1

32.8

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

32.6

655

4025

59000

ICD-8 Finland

Infections of kidney, Pyelonephritis chronica

+∞

32.3

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

31.9

492

2749

J01FF01

ATC

clindamycin; systemic

1.8

31.8

673

4203

KA3EB

NOMESCO Finland

Antegrade pyelography

88.7

31.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

31.7

856

5767

V03AE02

ATC

sevelamer; oral

+∞

31.3

M04AA01

ATC

allopurinol; systemic

2.2

31.3

355

1747

J01MA01

ATC

ofloxacin; systemic

2.4

31.1

274

1192

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.3

31.0

164

519

J01DA01

ATC

[U] cefalexin; systemic

1.6

30.8

1598

12809

S97

ICPC

Chronic ulcer skin

3.2

30.6

173

573

N03AX16

ATC

pregabalin; oral

1.9

30.5

575

3446

U02

ICPC

Urinary frequency/urgency

2.1

29.7

361

1829

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

29.7

290

1328

I50.0

ICD-10 Finland

Congestive heart failure

2.5

29.6

246

1035

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

10.8

29.5

R11

ICD-10 Finland

Nausea and vomiting

2.5

29.5

252

1079

205

Kela drug reimbursment

Chronic hypertension

1.7

29.3

787

5269

5909X

ICD-9 Finland

Infections of kidney, Infection of kidney, unspecified

+∞

29.2

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

28.7

1426

11212

J01XE01

ATC

nitrofurantoin; oral

5.0

28.5

194

B01AB05

ATC

enoxaparin; parenteral

1.7

28.5

754

5018

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

36.5

28.4

R4110

NOMESCO Finland

Physiotherapy

1.7

28.0

646

4120

H02AB06

ATC

prednisolone; systemic

1.6

27.7

1161

8718

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

27.7

445

2512

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

5.8

27.7

142

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.5

27.4

233

992

E86

ICD-10 Finland

Volume depletion

4.8

27.4

203

L04AD01

ATC

ciclosporin; systemic

6.8

27.3

106

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.6

27.3

127

364

A10AE05

ATC

insulin detemir; parenteral

3.0

27.2

164

569

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.7

27.2

123

344

U14

ICPC

Kidney symptom/complaint

9.2

27.2

N05AH04

ATC

quetiapine; oral

2.0

27.2

412

2275

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

+∞

27.1

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.8

26.6

179

667

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

26.1

415

2329

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

263.0

25.7

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.9

25.7

127

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.9

25.5

124

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

10.8

25.5

59358

ICD-8 Finland

Other diseases of kidney and ureter, Morbi ureteris alii

+∞

25.0

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

24.8

276

1338

N20.0

ICD-10 Finland

Calculus of kidney

5.8

24.6

126

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

24.5

261

1242

R32

ICD-10 Finland

Unspecified urinary incontinence

3.9

24.3

101

263

L04AA01

ATC

[U] ciclosporin; systemic

6.8

24.1

N30

ICD-10 Finland

Cystitis

2.4

24.1

212

919

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

+∞

24.0

Z43.5

ICD-10 Finland

Attention to cystostomy

19.2

23.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

23.8

1066

8040

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

126.1

23.6

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

5.4

23.4

134

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

23.4

393

2244

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

10.6

23.3

P01AB01

ATC

metronidazole; oral, rectal

1.6

23.3

937

6878

J01CA04

ATC

amoxicillin; systemic

1.6

23.3

1963

17048

L28

ICPC

Limited function/disability (L)

1.8

23.1

422

2482

A10BA02

ATC

metformin; oral

1.6

23.1

674

4561

C08CA01

ATC

amlodipine; oral

1.6

23.0

846

6073

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

+∞

22.9

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

22.9

252

1218

N05BA04

ATC

oxazepam; oral

1.6

22.5

643

4321

R06.0

ICD-10 Finland

Dyspnoea

1.7

22.3

612

4063

UJF32

NOMESCO Finland

Coloscopy

1.7

22.3

606

4018

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

9.7

22.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

22.3

276

1402

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

22.2

185

779

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.5

22.1

107

317

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

22.1

425

2539

KH1AD

NOMESCO Finland

CT of urinary organs

3.9

22.1

246

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.2

22.0

117

373

B03XA01

ATC

erythropoietin; parenteral

15.2

22.0

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

15.2

22.0

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.0

21.9

319

1727

KCD02

NOMESCO Finland

Transurethral resection of bladder

4.0

21.9

228

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

21.8

766

5422

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.7

21.8

264

SPAT1301

SPAT

No procedures

1.6

21.7

792

5661

TK820

NOMESCO Finland

Peritoneal dialysis

115.9

21.6

N40

ICD-10 Finland

Hyperplasia of prostate

1.7

21.4

489

3078

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.3

21.4

194

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.0

21.2

N05CF01

ATC

zopiclone; oral

1.5

21.2

825

5979

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

50.4

21.1

B01AA03

ATC

warfarin; systemic

1.6

21.0

578

3834

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.9

21.0

227

U05

ICPC

Urination problems other

2.9

21.0

132

472

L04AX01

ATC

azathioprine; systemic

3.1

20.9

120

403

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

24.4

20.8

H05BX01

ATC

cinacalcet; oral

21.6

20.8

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

4.4

20.5

170

R60.0

ICD-10 Finland

Localized oedema

2.0

20.4

285

1517

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

20.4

248

1248

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

10.7

20.4

M10.9

ICD-10 Finland

Gout, unspecified

2.5

20.4

162

666

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

5.1

20.3

127

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.5

20.3

167

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

20.2

220

1056

U01

ICPC

Dysuria/painful urination

2.3

20.2

197

898

N03AG01

ATC

valproic acid; systemic, rectal

2.6

20.1

153

612

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

7.8

20.0

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

20.0

429

2642

T90

ICPC

Diabetes non-insulin dependent

1.7

20.0

498

3207

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.7

19.9

243

A10BH01

ATC

sitagliptin; oral

2.1

19.8

223

1086

U08

ICPC

Urinary retention

5.1

19.7

123

SPAT1216

SPAT

Assessment of functional ability

1.8

19.6

396

2396

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

19.6

488

3145

U29

ICPC

Urinary symptom/complaint other

3.7

19.5

242

H3603, E103

ICD-10 Finland

9.6

19.3

R41.0

ICD-10 Finland

Disorientation, unspecified

3.2

19.3

104

336

G04AC01

ATC

3.0

19.1

111

377

KED22

NOMESCO Finland

Transurethral resection of prostate

2.4

19.1

161

683

SPAT1229

SPAT

Assessment of need for aid

2.1

19.1

223

1103

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

19.0

215

1048

A04

ICPC

Weakness/tiredness general

1.8

18.9

342

1997

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

18.8

227

1138

A10BH05

ATC

linagliptin; oral

2.9

18.7

118

423

A02BC01

ATC

omeprazole; systemic

1.5

18.7

695

4956

U04

ICPC

Incontinence urine

2.6

18.6

135

528

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

18.5

203

978

ZXA00

NOMESCO Finland

Right side

1.6

18.4

644

4526

M79.6

ICD-10 Finland

Pain in limb

1.5

18.2

797

5887

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

18.2

196

937

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

18.0

199

962

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

52.9

18.0

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

52.9

18.0

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

17.9

179

825

UKB02

NOMESCO Finland

Retrograde ureteroscopy

7.9

17.8

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

67.0

17.7

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.8

17.6

118

441

G04BD08

ATC

solifenacin; oral

2.2

17.6

180

841

N05AX08

ATC

risperidone; systemic

2.0

17.6

227

1172

R51.80

ICD-10 Finland

Headache

1.8

17.5

333

1971

JN4BD

NOMESCO Finland

Extensive body CT

1.9

17.4

252

1358

U13

ICPC

Bladder symptom/complaint other

3.2

17.4

294

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

17.3

777

5758

N06AX11

ATC

mirtazapine; oral

1.5

17.3

729

5328

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

17.3

605

4240

N06AB04

ATC

citalopram; systemic

1.6

17.2

528

3579

N05CD07

ATC

temazepam; oral

1.8

17.2

344

2067

B01AC04

ATC

clopidogrel; oral

1.7

17.2

373

2300

NHQ40

NOMESCO Finland

Amputation of toe

4.7

17.1

126

A10BB12

ATC

glimepiride; oral

2.1

17.1

212

1074

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

17.0

178

836

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.5

16.9

230

N05AA02

ATC

levomepromazine; systemic

2.8

16.8

111

408

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

16.7

571

3973

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

+∞

16.7

N13.2

ICD-10 Finland

Hydronephrosis with renal and ureteral calculous obstruction

+∞

16.7

SPAT1252

SPAT

Overall medication plan or its review

2.1

16.6

190

932

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

16.6

293

1694

TKC22

NOMESCO Finland

Catheterisation instruction

4.3

16.5

144

V03AE03

ATC

lanthanum carbonate; oral

171.0

16.5

J02AC01

ATC

fluconazole; systemic

1.4

16.5

915

7067

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

20.2

16.4

Z71.8

ICD-10 Finland

Other specified counselling

1.6

16.4

515

3510

R35

ICD-10 Finland

Polyuria

2.3

16.3

154

692

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.7

16.2

196

M54.5

ICD-10 Finland

Low back pain

1.5

16.2

712

5241

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

4.9

16.1

107

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

30.2

16.1

N20.1

ICD-10 Finland

Calculus of ureter

3.0

16.1

322

N06AX21

ATC

duloxetine; oral

1.9

16.0

242

1323

KH1EE

NOMESCO Finland

Urologic ultrasound examination

18.6

16.0

ZXA05

NOMESCO Finland

Left side

1.5

16.0

608

4332

C09AA05

ATC

ramipril; oral

1.5

15.9

593

4203

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

15.9

206

1063

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

15.8

115

452

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.5

15.7

124

U99

ICPC

Urinary disease other

9.8

15.7

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

+∞

15.6

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

+∞

15.6

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

15.6

404

2615

N05BA01

ATC

diazepam; systemic, rectal

1.7

15.6

323

1964

KH1AT

NOMESCO Finland

Urinary tract cathetrisation with ultrasound guidance

22.2

15.5

A07AA09

ATC

vancomycin; oral

5.0

15.5

JN4AD

NOMESCO Finland

Body CT examination

2.2

15.4

167

799

XJH00

NOMESCO Finland

Transanal ultrasonography

2.2

15.4

164

778

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

15.4

128

541

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.9

15.3

332

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

15.3

182

909

C02AC05

ATC

moxonidine; oral

2.6

15.2

108

418

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

15.2

489

3346

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

15.1

414

2718

N06AB10

ATC

escitalopram; oral

1.6

15.1

434

2889

J01FA06

ATC

roxithromycin; oral

1.4

15.0

940

7399

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.3

15.0

231

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.8

14.9

349

G04BD04

ATC

oxybutynin; oral, transdermal

2.1

14.9

168

817

KBV00

NOMESCO Finland

Insertion of stent into ureter

12.5

14.8

C01DA14

ATC

isosorbide mononitrate; oral

1.6

14.8

449

3027

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

14.8

104

400

AN1

Coronary angiography

1.8

14.8

291

1740

TK810

NOMESCO Finland

Hemofiltration

31.9

14.8

WW500

NOMESCO Finland

Blood transfusion

2.7

14.8

101

383

U06

ICPC

Haematuria

3.6

14.8

186

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

14.8

908

7115

KAT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pelvis of kidney

7.2

14.8

N05AH03

ATC

olanzapine; systemic

2.3

14.8

133

586

R03AC02

ATC

salbutamol; inhalant

1.4

14.7

1195

9838

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

14.7

612

4437

A10AA01

ATC

3.5

14.6

203

SPAT1251

SPAT

Organisation of medication

2.5

14.6

116

477

59012

ICD-8 Finland

Infections of kidney, Pyelocystitis

+∞

14.6

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

14.6

258

1491

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

14.6

581

4173

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

14.5

239

1347

C09AA02

ATC

enalapril; systemic

1.5

14.5

487

3366

N03AX12

ATC

gabapentin; oral

1.7

14.4

336

2108

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.4

14.4

201

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

14.4

332

2080

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

14.3

397

2617

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

14.3

123

528

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

14.1

186

964

J01MA14

ATC

moxifloxacin; systemic

1.9

14.1

208

1126

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

14.1

369

2392

321

Kela drug reimbursment

Paricalcitol and cinacalcet

14.5

14.0

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

14.0

150

714

E87.5

ICD-10 Finland

Hyperkalaemia

4.9

14.0

SPAT1125

SPAT

Stoma care and guidance

3.9

14.0

144

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

13.9

596

4343

J01XX05

ATC

methenamine; oral

5.0

13.8

H02AB04

ATC

methylprednisolone; systemic

1.7

13.8

336

2134

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

6.0

13.8

WX110

NOMESCO Finland

Local anesthesy

1.4

13.7

1496

12875

N03AF01

ATC

carbamazepine; oral, rectal

2.2

13.7

143

675

M05BA04

ATC

alendronic acid; oral

1.8

13.6

237

1362

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

13.6

108

447

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

+∞

13.5

N13.6

ICD-10 Finland

Pyonephrosis

+∞

13.5

A10AA02

ATC

2.6

13.5

372

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

140.7

13.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.7

13.3

334

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

13.2

484

3400

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

6.4

13.2

T89

ICPC

Diabetes insulin dependent

2.8

13.1

310

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

13.1

162

822

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

15.1

13.1

X58

ICD-10 Finland

Exposure to other specified factors

1.7

13.0

273

1662

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

13.0

167

858

KA1FN

NOMESCO Finland

Isotope renography

10.1

13.0

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

6.4

12.9

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.0

12.9

258

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

2.0

12.8

166

859

R39.1

ICD-10 Finland

Other difficulties with micturition

3.1

12.7

232

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.4

12.7

183

R30.0

ICD-10 Finland

Dysuria

2.7

12.7

337

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

12.7

116

516

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.8

12.7

WX882

NOMESCO Finland

High dependency care

3.0

12.6

242

WX892

NOMESCO Finland

Monitored bed care

2.0

12.6

167

871

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

12.6

577

4248

N06AA09

ATC

amitriptyline; systemic

1.8

12.6

227

1320

Z93.6

ICD-10 Finland

Other artificial openings of urinary tract status

70.2

12.6

N05AF03

ATC

chlorprothixene; systemic

3.2

12.5

207

R42

ICD-10 Finland

Dizziness and giddiness

1.5

12.5

517

3725

N05AB03

ATC

perphenazine; systemic, rectal

2.6

12.5

341

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

12.5

112

494

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

3.5

12.5

165

XKC03

NOMESCO Finland

Water cystometry

2.8

12.4

297

N99.5

ICD-10 Finland

Malfunction of external stoma of urinary tract

130.6

12.4

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

12.3

245

1466

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

12.3

192

1063

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

12.3

444

3109

N21.0

ICD-10 Finland

Calculus in bladder

5.2

12.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

12.1

263

1617

G04BD07

ATC

tolterodine; oral

2.1

12.1

141

699

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

7.0

12.1

A01

ICPC

Pain general/multiple sites

1.9

12.1

180

980

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.6

12.0

342

EBA00

NOMESCO Finland

Extraction of tooth

1.4

12.0

660

5027

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

11.9

768

6011

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.0

11.9

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

11.9

254

1555

N20.9

ICD-10 Finland

Urinary calculus, unspecified

3.2

11.9

199

C08CA02

ATC

felodipine; oral

1.7

11.9

232

1382

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

11.8

162

855

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.8

11.8

261

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

14.7

11.8

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.1

11.7

134

658

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.2

11.7

120

563

H02AB09

ATC

hydrocortisone; systemic

3.3

11.7

179

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

12.6

11.6

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

11.6

282

1791

A10AE06

ATC

insulin degludec; parenteral

3.0

11.6

214

S18

ICPC

Laceration/cut

1.4

11.5

894

7218

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

8.6

11.5

RS221

NOMESCO Finland

4.1

11.5

105

ZZA00

NOMESCO Finland

Split skin graft

2.6

11.5

325

N13.8

ICD-10 Finland

Other obstructive and reflux uropathy

+∞

11.5

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.8

11.4

Z43.6

ICD-10 Finland

Attention to other artificial openings of urinary tract

120.5

11.4

3025

Kela drug reimbursment

Calcium carbonate

120.5

11.4

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

7.5

11.4

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

5.1

11.4

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

11.4

104

462

C08CA13

ATC

lercanidipine; oral

1.6

11.4

290

1864

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

11.3

154

810

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.2

11.3

179

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

11.3

121

578

Z51.5

ICD-10 Finland

Palliative care

2.0

11.3

139

704

N30.2

ICD-10 Finland

Other chronic cystitis

5.0

11.2

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

11.2

199

1151

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

11.2

683

5287

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.0

11.2

208

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.0

11.2

108

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

11.1

141

724

A12BA01

ATC

potassium chloride; oral

1.9

11.1

151

796

J01AA02

ATC

doxycycline; systemic

1.3

11.0

1831

16523

C10AA01

ATC

simvastatin; oral

1.3

11.0

981

8073

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

11.0

596

4515

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.8

11.0

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

11.0

349

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.0

10.9

200

SPAT1104

SPAT

Monitoring of emergency patient

1.9

10.9

151

800

U28

ICPC

Limited function/disability (U)

5.1

10.9

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.9

10.9

165

906

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.5

10.9

141

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

10.9

347

2359

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

10.8

153

819

N06AX16

ATC

venlafaxine; oral

1.6

10.8

272

1745

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.0

10.8

KAC00

NOMESCO Finland

Nephrectomy

10.6

10.8

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

10.7

105

481

RF210

NOMESCO Finland

2.7

10.7

264

NFQ20

NOMESCO Finland

Amputation of femur

5.4

10.7

N06AB03

ATC

fluoxetine; oral

1.6

10.7

263

1676

T83.0

ICD-10 Finland

Mechanical complication of urinary (indwelling) catheter

12.9

10.6

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

10.6

314

2094

SPAT1171

SPAT

Bladder puncture

60.2

10.6

S01.0

ICD-10 Finland

Open wound of scalp

1.8

10.5

171

958

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

11.2

10.5

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

10.5

388

3AC01

NOMESCO Finland

4.9

10.5

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.0

10.5

204

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.9

10.4

224

E66.8

ICD-10 Finland

Other obesity

2.3

10.4

442

5910A

ICD-9 Finland

Hydronephrosis[HYDRONEPHROSIS]

+∞

10.4

N15.9

ICD-10 Finland

Renal tubulo-interstitial disease, unspecified

+∞

10.4

N05AA01

ATC

chlorpromazine; systemic, rectal

4.8

10.4

SPAT1260

SPAT

Consultation of another employee

1.5

10.4

386

2714

WX002

NOMESCO Finland

Sedation and analgesia

1.5

10.3

421

3017

R07.3

ICD-10 Finland

Other chest pain

1.7

10.3

201

1195

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.4

10.3

148

H36.01

ICD-10 Finland

Diabetic maculopathy

4.2

10.2

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.9

10.2

160

Kela drug reimbursment

exenatide

3.6

10.2

123

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.1

10.2

120

598

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

10.2

772

6184

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.5

10.1

325

H3603, E113

ICD-10 Finland

5.4

10.1

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

10.1

173

990

F05.9

ICD-10 Finland

Delirium, unspecified

3.1

10.1

172

E0000UV

ATC

1.3

10.1

864

7047

N18

ICD-10 Finland

Chronic kidney disease

7.9

10.1

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

10.0

870

7106

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

10.0

204

1232

R03BB04

ATC

tiotropium bromide; inhalant

1.7

10.0

223

1380

M10.3

ICD-10 Finland

Gout due to impairment of renal function

14.6

10.0

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

40.2

10.0

S72.0

ICD-10 Finland

Fracture of neck of femur

2.1

9.9

114

562

N30.8

ICD-10 Finland

Other cystitis

5.8

9.9

R4120

NOMESCO Finland

Occupational therapy

2.0

9.9

133

696

S06.0

ICD-10 Finland

Concussion

1.7

9.9

219

1352

K92.1

ICD-10 Finland

Melaena

2.0

9.9

119

600

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.6

9.9

272

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

9.8

643

5021

Y0699

ICD-8 Finland

Examination of the urinary and genital organs, Urinary organs. Does not include urine tests to determine endocrine and metabolic disorders (Y 00.99)

5.0

9.8

C07AB02

ATC

metoprolol; systemic

1.4

9.8

526

3966

M03BX01

ATC

baclofen; systemic

3.5

9.8

127

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

9.8

140

751

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

7.0

9.8

N05AH02

ATC

clozapine; systemic

3.7

9.8

112

N06AB06

ATC

sertraline; oral

1.7

9.7

219

1360

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

9.7

298

2006

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

9.7

816

6632

A07AA02

ATC

nystatin; oral

1.9

9.7

145

794

K65.0

ICD-10 Finland

Acute peritonitis

4.2

9.6

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

3.3

9.6

145

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.1

9.6

KBV10

NOMESCO Finland

Removal of stent from ureter

6.8

9.6

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.1

9.6

107

523

W19

ICD-10 Finland

Unspecified fall

1.7

9.6

209

1287

B34.9

ICD-10 Finland

Viral infection, unspecified

2.8

9.6

208

B01AB10

ATC

tinzaparin; parenteral

1.9

9.5

134

715

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.6

9.5

274

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.6

9.5

256

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

9.5

284

R80

ICD-10 Finland

Isolated proteinuria

6.0

9.5

H04AA01

ATC

glucagon; nasal, parenteral

3.1

9.4

164

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

9.4

106

520

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

100.4

9.4

Q62.10

ICD-10 Finland

Congenital unilateral occlusion of the pelvic ureteral junction

100.4

9.4

N03AX09

ATC

lamotrigine; oral

2.2

9.4

426

SPAT1211

SPAT

Application of soft bandage

1.7

9.3

194

1179

M48.0

ICD-10 Finland

Spinal stenosis

1.6

9.3

260

1709

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

8.7

9.3

N18

ICPC

Paralysis/weakness

3.0

9.3

172

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

9.3

160

918

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.2

9.2

150

J96.1

ICD-10 Finland

Chronic respiratory failure

2.9

9.2

195

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.0

9.2

120

626

R55

ICD-10 Finland

Syncope and collapse

1.6

9.1

250

1638

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

3.4

9.1

125

59902

ICD-8 Finland

Other diseases of urinary tract, Infectiones tractuum urinariorum NUD

5.9

9.0

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

9.0

122

642

G04BD12

ATC

mirabegron; oral

1.7

9.0

207

1292

A41.4

ICD-10 Finland

Sepsis due to anaerobes

15.6

9.0

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.7

9.0

75348

ICD-8 Finland

Congenital anomalies of urinary system, Maleformationes ureteris aliae

36.8

9.0

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.6

9.0

241

58209

ICD-8 Finland

Chronic nephritis, Unspecified

18.6

8.9

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

8.9

343

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.1

8.9

R05FB02

ATC

cough suppressants and expectorants

1.3

8.9

864

7151

N05CF02

ATC

zolpidem; oral

1.5

8.8

355

2530

K02.1

ICD-10 Finland

Caries of dentine

1.3

8.8

1140

9796

KAE12

NOMESCO Finland

Retrograde ureteronephroscopic lithotripsy in pelvis of kidney

8.6

8.8

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

8.8

475

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

8.8

301

E87.6

ICD-10 Finland

Hypokalaemia

2.4

8.7

313

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

8.7

580

4532

N05BA12

ATC

alprazolam; oral

1.6

8.7

215

1373

7151

FHL

Kidney transplantation

50.1

8.7

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

50.1

8.7

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

50.1

8.7

C03AA03

ATC

hydrochlorothiazide; oral

1.6

8.7

221

1422

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

8.6

557

4327

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

8.6

107

548

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.7

8.6

203

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

8.6

537

4148

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

8.6

107

549

KCC10

NOMESCO Finland

Cystoprostatectomy

8.2

8.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

8.6

163

967

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.0

8.5

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

8.5

114

600

K59.0

ICD-10 Finland

Constipation

1.8

8.5

139

787

KA3GB

NOMESCO Finland

Retrograde pyelography

20.1

8.5

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

20.1

8.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

8.5

249

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.8

8.4

135

757

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

4.0

8.4

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

90.3

8.4

1530

FHL

Urethrocystoscopy

2.8

8.4

193

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

8.4

117

626

K08.3

ICD-10 Finland

Retained dental root

1.8

8.4

136

766

G04AB05

ATC

2.3

8.4

319

A02BA02

ATC

ranitidine; systemic

1.4

8.4

461

3490

C09CA01

ATC

losartan; oral

1.4

8.3

491

3756

RJ411

NOMESCO Finland

6.7

8.3

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.8

8.3

185

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

+∞

8.3

59199

ICD-8 Finland

Hydronephrosis

+∞

8.3

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

+∞

8.3

N25.0

ICD-10 Finland

Renal osteodystrophy

+∞

8.3

5900A

ICD-9 Finland

Infections of kidney, Chronic pyelonephritis

+∞

8.3

N15.1

ICD-10 Finland

Renal and perinephric abscess

+∞

8.3

R02

ICPC

Shortness of breath/dyspnoea

1.5

8.3

249

1665

E000001

ATC

1.4

8.3

435

3259

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.3

8.3

118

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

8.3

606

4798

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

4.6

8.3

G04CA01

ATC

alfuzosin; oral

1.6

8.2

219

1424

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

8.2

345

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

8.2

316

QBG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of trunk

14.5

8.2

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

14.5

8.2

QBG10

NOMESCO Finland

Excision and repair of bedsore of trunk

14.5

8.2

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

8.2

225

1476

J01CF05

ATC

flucloxacillin; systemic

2.2

8.2

349

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

8.1

298

2085

-1

NOMESCO Finland

1.3

8.1

654

5255

TKD00

NOMESCO Finland

Dilatation of urethra

4.2

8.1

Z93.5

ICD-10 Finland

Cystostomy status

17.2

8.1

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

8.1

416

3111

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

8.1

531

4136

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.8

8.1

N04AA02

ATC

biperiden; systemic

2.9

8.0

165

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

8.0

156

933

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

7.9

174

1076

C02CA01

ATC

prazosin; oral

2.8

7.9

167

H02AB07

ATC

prednisone; oral

1.5

7.9

311

2208

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.0

7.9

145

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.4

7.9

RD210

NOMESCO Finland

3.3

7.9

112

-35

ICPC

Urine test

3.2

7.9

123

P29

ICPC

Psychological sympt/compl other

1.9

7.9

105

552

K90

ICPC

Stroke/cerebrovascular accident

2.3

7.9

298

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.4

7.9

107

L29

ICPC

Musculoskeletal sympt/complt other

1.7

7.9

148

874

A29

ICPC

General symptom/complaint other

1.5

7.9

235

1572

H26.3

ICD-10 Finland

Drug-induced cataract

7.8

7.9

ZX108

NOMESCO Finland

Inhalation

6.1

7.8

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.2

7.8

124

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.3

7.8

A49

ICD-10 Finland

Bacterial infection of unspecified site

8.5

7.8

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.0

7.8

477

N05AD01

ATC

haloperidol; systemic

2.1

7.8

391

R10.0

ICD-10 Finland

Acute abdomen

2.3

7.8

313

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.1

7.8

G04AA01

ATC

3.6

7.7

Z46.6

ICD-10 Finland

Fitting and adjustment of urinary device

45.1

7.7

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

45.1

7.7

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

7.7

131

WVA20

NOMESCO Finland

Medicine administration

2.8

7.7

165

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

7.7

426

3225

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.3

7.7

288

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

4.6

7.7

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.5

7.7

220

S19

ICPC

Skin injury other

2.1

7.7

410

K07

ICPC

Swollen ankles/oedema

2.0

7.7

501

EBA30

NOMESCO Finland

Excision of root of tooth

1.9

7.6

103

544

P72

ICPC

Schizophrenia

3.3

7.6

110

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

7.6

248

1691

SPAT1234

SPAT

Support of social functional capacity

1.8

7.6

122

684

G47.3

ICD-10 Finland

Sleep apnoea

1.4

7.6

355

2603

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.2

7.6

331

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

7.6

211

1386

KK1XE

NOMESCO Finland

Other ultrasound examination of retroperitoneal space and genito-urinary tract

18.4

7.6

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

7.6

178

1120

B81

ICPC

Anaemia vit B12/folate deficiency

2.0

7.5

442

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

8.9

7.5

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

6.2

7.5

WX320

NOMESCO Finland

Spinalanesthesy

1.4

7.5

461

3547

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.6

7.5

R4190

NOMESCO Finland

Nutritional therapy

2.4

7.5

255

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

7.5

117

651

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

7.5

436

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.0

7.5

140

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

7.4

128

735

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.6

7.4

WX402

NOMESCO Finland

General anaesthesia

1.5

7.4

298

2125

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

7.4

205

1347

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.2

7.4

118

L04AA05

ATC

[U] tacrolimus; systemic

80.3

7.4

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

7.4

178

1126

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

5.0

7.4

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

7.4

508

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

4.2

7.4

H3601, E113

ICD-10 Finland

3.2

7.4

113

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

7.4

222

1486

N05AX12

ATC

aripiprazole; systemic

2.3

7.4

281

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

7.4

878

7419

G82.2

ICD-10 Finland

Paraplegia, unspecified

6.0

7.4

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

7.3

431

3289

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.4

7.3

251

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.0

7.3

432

A02BC05

ATC

esomeprazole; systemic

1.3

7.3

863

7279

WX704

NOMESCO Finland

Intubation

1.7

7.3

131

765

SPAT1097

SPAT

Recording of ECG

1.4

7.3

303

2173

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.7

7.3

183

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

+∞

7.3

5937A

ICD-9 Finland

Other disorders of kidney and ureter, Vesicoureteric reflux

+∞

7.3

N13.7

ICD-10 Finland

Vesicoureteral-reflux-associated uropathy

+∞

7.3

5AB14

NOMESCO Finland

+∞

7.3

C03DA01

ATC

spironolactone; oral

1.5

7.3

237

1614

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.9

7.3

146

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

6.8

7.3

A10BJ02

ATC

liraglutide; parenteral

2.7

7.3

166

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.8

7.3

160

Z93.3

ICD-10 Finland

Colostomy status

5.2

7.2

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

5.2

7.2

KCW96

NOMESCO Finland

Other operations on bladder

5.8

7.2

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.2

386

2904

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.7

7.2

179

Q61.0

ICD-10 Finland

Congenital single renal cyst

30.1

7.1

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.1

7.1

122

U72

ICPC

Urethritis

2.5

7.1

215

RJ420

NOMESCO Finland

6.6

7.1

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.0

7.1

461

G04BD09

ATC

trospium; oral

2.3

7.1

282

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

7.1

411

N05AF05

ATC

zuclopenthixol; systemic

4.5

7.1

WNF00

NOMESCO Finland

Infection source and contact determination

5.6

7.1

I95.9

ICD-10 Finland

Hypotension, unspecified

3.3

7.0

101

J96.0

ICD-10 Finland

Acute respiratory failure

3.2

7.0

112

Z75.5

ICD-10 Finland

Holiday relief care

3.2

7.0

112

J01DA06

ATC

[U] cefuroxime; systemic

1.4

7.0

302

2181

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

7.0

446

3447

ZX136

NOMESCO Finland

Intravesicalis

4.3

7.0

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.7

7.0

G72.8

ICD-10 Finland

Other specified myopathies

3.2

7.0

107

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

7.0

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

7.0

405

H3600, E103

ICD-10 Finland

4.1

7.0

D64.8

ICD-10 Finland

Other specified anaemias

3.0

7.0

124

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.1

7.0

357

D12

ICPC

Constipation

2.0

7.0

393

N35.9

ICD-10 Finland

Urethral stricture, unspecified

3.6

7.0

A08AA02

ATC

fenfluramine; oral (centrally acting antiobesity products)

3.7

6.9

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

4.5

6.9

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

6.9

270

NGQ20

NOMESCO Finland

Amputation of lower leg

5.8

6.9

K65.9

ICD-10 Finland

Peritonitis, unspecified

7.5

6.9

I12.9

ICD-10 Finland

Hypertensive renal disease without renal failure

13.8

6.9

U27

ICPC

Fear of urinary disease other

4.6

6.9

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

6.9

260

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

3.5

6.9

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.9

1481

13371

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.7

6.9

163

D11

ICPC

Diarrhoea

1.5

6.8

200

1333

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.6

6.8

189

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.4

6.8

M01AH02

ATC

rofecoxib; oral

1.4

6.8

283

2029

Z03

ICPC

Housing/neighbourhood problem

4.2

6.8

Angiography of the heart and coronary arteries

1.6

6.8

159

1001

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

6.8

303

2206

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

6.8

391

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.5

6.8

198

L14

ICPC

Leg/thigh symptom/complaint

1.7

6.8

143

878

KCB00

NOMESCO Finland

Biopsy of bladder

5.7

6.7

N05AC02

ATC

thioridazine; oral

2.6

6.7

174

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

6.7

113

647

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.3

6.7

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

6.7

144

888

I20.00

ICD-10 Finland

Unstable angina

2.0

6.7

399

N20.2

ICD-10 Finland

Calculus of kidney with calculus of ureter

7.2

6.7

L30.4

ICD-10 Finland

Erythema intertrigo

3.5

6.7

N06AX03

ATC

mianserin; oral

1.8

6.7

101

558

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.7

6.7

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

6.7

456

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.0

6.7

117

A10BH02

ATC

vildagliptin; oral

2.6

6.7

169

X57

ICD-10 Finland

Unspecified privation

2.5

6.6

194

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

6.6

105

591

S82.3

ICD-10 Finland

Fracture of lower end of tibia

2.7

6.6

162

N05BB01

ATC

hydroxyzine; systemic

1.7

6.6

138

843

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.3

6.6

243

SPAT1138

SPAT

Guidance concerning bowel function

2.8

6.6

146

L03

ICPC

Low back symptom/complaint

1.3

6.6

468

3678

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

6.6

306

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.5

6.6

188

WZC30

NOMESCO Finland

Teaching

1.5

6.6

240

1679

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

3.5

6.6

KC1AT

NOMESCO Finland

Puncture of urinary bladder with ultrasound guidance

12.3

6.6

A10BJ06

ATC

semaglutide; parenteral

2.4

6.6

226

D01

ICPC

Abdominal pain/cramps general

1.5

6.5

202

1362

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

10.0

6.5

S17

ICPC

Abrasion/scratch/blister

2.4

6.5

208

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

6.5

228

1580

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

6.5

175

1142

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.4

6.5

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.1

6.5

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.3

6.5

248

D01AC02

ATC

miconazole; topical

1.6

6.5

167

1080

C08CA05

ATC

nifedipine; systemic

1.6

6.5

156

992

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

6.5

389

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.5

6.5

191

N03AE01

ATC

clonazepam; systemic

1.8

6.5

112

647

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

6.4

146

912

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

5.7

6.4

I25.2

ICD-10 Finland

Old myocardial infarction

1.6

6.4

171

1112

Z99.2

ICD-10 Finland

Dependence on renal dialysis

70.0

6.4

R52.2

ICD-10 Finland

Other chronic pain

2.2

6.4

295

D07AC01

ATC

betamethasone; topical

1.3

6.4

710

5929

QBG00

NOMESCO Finland

Debridement of bedsore of trunk

14.3

6.4

30660

ICD-8 Finland

Special symptoms not elsewhere classified, Enuresis

14.3

6.4

M54.1

ICD-10 Finland

Radiculopathy

2.1

6.4

331

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

6.4

408

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.5

6.4

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.6

6.4

161

WX872

NOMESCO Finland

Intensive care

1.9

6.4

480

N39

ICD-10 Finland

Other disorders of urinary system

3.8

6.4

SPAT1285

SPAT

Provision of consultation response

1.7

6.3

113

659

A35

ICPC

General and Unspecified, Urine test

4.9

6.3

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

6.3

323

1DC02

NOMESCO Finland

8.2

6.3

A08AA01

ATC

phentermine; oral

8.2

6.3

E11.01

ICD-10 Finland

Non-insulin dependent diabetes diabetic coma with hyperglycaemia

8.2

6.3

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.5

6.3

197

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

6.3

116

684

C08DB01

ATC

diltiazem; oral

1.6

6.3

138

856

KC1AE

NOMESCO Finland

Percutaneous ultrasound examination of urinary bladder

9.3

6.3

A10BX04

ATC

[U] exenatide; parenteral

4.0

6.3

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.6

6.3

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

6.3

183

1220

P15

ICPC

Chronic alcohol abuse

2.7

6.3

146

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

+∞

6.2

PC6DE

NOMESCO Finland

+∞

6.2

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

+∞

6.2

N11.1

ICD-10 Finland

Chronic obstructive pyelonephritis

+∞

6.2

M10.0

ICD-10 Finland

Idiopathic gout

2.2

6.2

271

N00.9

ICD-10 Finland

Acute nephritic syndrome, Unspecified

26.7

6.2

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.8

6.2

527

I50

ICD-10 Finland

Heart failure

2.0

6.2

356

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

3.5

6.2

E83.51

ICD-10 Finland

Hypocalcemia

5.0

6.2

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

6.2

546

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

6.1

192

1301

S76

ICPC

Skin infection other

1.8

6.1

100

567

K56.0

ICD-10 Finland

Paralytic ileus

3.4

6.1

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.4

6.1

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

1.8

6.1

553

Z72.1

ICD-10 Finland

Alcohol use

3.5

6.1

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

6.1

351

W17

ICD-10 Finland

Other fall from one level to another

1.9

6.1

431

KBH20

NOMESCO Finland

Replantation of ureter

12.5

6.1

3400A

ICD-9 Finland

Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]

12.5

6.1

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

6.1

525

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

6.0

480

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.9

6.0

S22.3

ICD-10 Finland

Fracture of rib

1.7

6.0

122

739

H3600, E113

ICD-10 Finland

3.0

6.0

103

WW200

NOMESCO Finland

Immunization

2.3

6.0

218

PE1AT

NOMESCO Finland

Femoral artery PTA

3.2

6.0

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

6.0

110

649

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.4

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

1295

5521

3.40

223.76

6.8

3.6

—

(3026008) Bacteria identified in Urine by Culture

1475

6919

3.26

215.17

5.8

2.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

491

1310

4.30

166.45

12.2

3.7

12.4

8.0

mmol/l

24.42

457

1228

(3003458) Phosphate [Moles/volume] in Serum or Plasma

629

2277

3.24

133.27

10.7

3.0

1.1

1.0

mmol/l

7.89

589

2058

(3000850) Epithelial cells [#/volume] in Urine

960

4435

2.73

129.95

4.6

2.2

6.1

6.0

e6/l

0.06

860

3841

(3002582) Erythrocytes [#/volume] in Urine

1210

6407

2.50

121.91

6.3

2.7

55.4

88.5

e6/l

1.17

1015

4856

(3018095) Leukocytes [#/volume] in Urine

1334

7633

2.36

110.16

7.2

3.1

201.9

83.7

e6/l

3.76

1059

5262

(3026782) Osmolality of Urine

877

4167

2.57

109.15

5.0

2.3

507.4

560.6

mosm/kgh2o

11.21

771

3491

(3030467) Casts [#/volume] in Urine by Automated count

1069

5850

2.30

94.60

6.1

2.7

0.4

0.5

e6/l

0.76

877

4369

(3026250) Tacrolimus [Mass/volume] in Blood

30.13

93.80

36.7

23.8

7.0

6.8

ug/l

0.20

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

414

1424

3.22

93.41

2.1

1.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2085

15083

2.30

90.41

9.6

4.2

1877.1

1598.8

e6/l

0.13

217

(36304419) Bacteria [Presence] in Urine

1036

5714

2.25

88.83

6.0

2.6

—

(40768446) Kidney Pathology biopsy report

35.96

84.46

1.9

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

173

365

4.97

77.22

6.2

3.2

2.0

1.2

mg/l

17.57

164

333

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

701

3492

2.32

74.72

2.3

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

436

1756

2.74

73.08

6.6

2.6

5.8

5.9

kpa

0.51

417

1699

(3037467) Urinalysis macro (dipstick) panel - Urine

2063

15484

2.10

72.43

8.3

3.9

—

(3002032) Base excess in Venous blood by calculation

431

1743

2.72

71.58

6.7

2.6

1.1

2.2

mmol/l

6.72

356

1397

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

367

1386

2.88

69.32

7.3

2.2

133.2

70.2

ng/l

11.79

320

1148

(3000991) Gas panel - Venous blood

384

1510

2.77

67.12

10.5

6.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

636

3222

2.24

63.99

4.1

1.9

11.4

13.1

umol/l

7.86

592

2933

(3012095) Magnesium [Moles/volume] in Serum or Plasma

628

3169

2.25

63.77

4.0

2.7

0.8

mmol/l

1.88

590

2897

(3004789) Transferrin [Mass/volume] in Serum or Plasma

592

2920

2.28

63.48

4.1

1.8

2.2

2.4

g/l

8.43

553

2665

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1567

10979

1.91

63.21

11.8

5.0

1.2

mmol/l

1.49

1329

9191

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

556

2677

2.33

63.08

4.3

1.8

21.0

22.6

1.82

477

2239

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1076

6674

1.96

62.58

3.4

2.3

55.5

57.6

u/l

0.32

1001

6097

(3024561) Albumin [Mass/volume] in Serum or Plasma

1382

9404

1.88

59.93

7.4

3.8

33.5

35.5

g/l

25.60

1287

8615

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1581

11238

1.88

59.64

7.3

5.4

10.5

11.7

umol/l

4.11

1501

10559

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

233

741

3.33

58.94

2.2

1.8

2.0

1.8

ug/l

0.09

208

624

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

246

816

3.20

58.05

7.1

2.5

23.4

24.5

mmol/l

5.12

220

722

(3035350) Ketones [Presence] in Urine by Test strip

1523

10769

1.86

57.70

7.0

3.4

0.0

estimate

0.50

316

1928

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

503

2422

2.30

56.55

2.2

1.7

—

(3009343) pH of Capillary blood

300

1145

2.80

55.09

5.3

2.7

7.4

0.34

100

(3014576) Chloride [Moles/volume] in Serum or Plasma

513

2518

2.26

54.97

7.9

5.8

104.0

104.4

mmol/l

1.12

494

2456

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

625

3322

2.12

54.78

5.4

2.4

4.1

2.7

e6/l

1.54

389

1791

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1410

9840

1.83

54.73

10.1

4.6

1.2

mmol/l

0.05

1304

8781

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

302

1161

2.78

54.69

5.3

2.7

5.2

kpa

0.01

284

1055

(3007853) Bacteria identified in Skin by Aerobe culture

497

2424

2.26

54.01

2.3

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

1525

10935

1.82

53.78

7.1

3.5

0.0

estimate

0.09

312

1908

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

306

1198

2.73

53.46

1.8

1.4

—

(3042733) HLA Ab [Presence] in Serum

24.05

53.05

5.7

2.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

288

1103

2.79

52.46

5.2

2.6

2.0

2.1

mmol/l

0.30

211

806

(3024354) Oxygen [Partial pressure] in Venous blood

352

1497

2.53

51.97

5.0

2.6

5.0

4.4

kpa

4.21

337

1448

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

491

2424

2.23

51.63

2.2

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

1501

10803

1.79

51.41

9.2

4.6

0.0

estimate

0.50

315

1943

(3032080) INR in Blood by Coagulation assay

1285

8849

1.80

50.98

12.7

9.3

1.3

inr

0.13

395

2506

(3015235) Bicarbonate [Moles/volume] in Capillary blood

158

432

3.81

50.20

3.9

2.7

24.6

25.8

mmol/l

2.15

142

367

(3042936) Bacteria identified in Isolate by Culture

545

2835

2.13

50.10

2.8

1.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

277

1065

2.77

50.02

4.8

2.2

0.3

e6/l

0.00

270

1033

(3019069) Monocytes/100 leukocytes in Blood

1418

10116

1.77

49.34

8.3

5.7

8.6

0.13

1320

9390

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

187

579

3.38

49.25

3.4

2.8

0.3

0.4

u/ml

0.81

324

(3022096) Basophils/100 leukocytes in Blood

1375

9743

1.77

48.80

8.0

5.4

0.6

0.7

6.30

1280

9017

(1616796) Gas panel - Central venous blood

138

350

4.09

48.68

4.9

2.5

—

(3006504) Eosinophils/100 leukocytes in Blood

1409

10060

1.77

48.65

8.0

5.4

2.8

0.29

1312

9284

(3018418) pH of Serum or Plasma

996

6424

1.83

48.53

7.4

2.9

7.4

1.68

202

1153

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

127

306

4.29

47.96

8.7

4.1

556.2

924.9

iu/ml

0.23

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

636

3560

2.00

47.67

5.0

2.3

1.4

1.3

e6/l

0.24

399

2008

(3028626) Oxygen [Partial pressure] in Capillary blood

146

393

3.86

47.42

3.5

2.7

8.2

7.9

kpa

1.23

137

353

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

183

576

3.32

46.92

1.4

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

1437

10391

1.75

46.83

8.2

5.5

25.5

27.8

10.65

1344

9601

(3006315) Basophils [#/volume] in Blood

1477

10776

1.74

46.51

7.9

5.3

0.0

e9/l

2.98

1282

9244

(3018010) Neutrophils/100 leukocytes in Blood

1420

10250

1.74

46.43

8.0

5.3

59.5

57.5

7.59

1328

9514

(3013650) Neutrophils [#/volume] in Blood by Automated count

1661

12562

1.74

45.62

11.8

7.9

4.6

4.1

e9/l

12.11

1461

10892

(3001604) Monocytes [#/volume] in Blood

1468

10733

1.73

45.52

7.9

5.2

0.6

e9/l

3.65

1274

9202

(3019198) Lymphocytes [#/volume] in Blood

1502

11056

1.73

45.41

8.0

5.3

1.9

e9/l

0.04

1342

9664

(3027801) Oxygen [Partial pressure] in Arterial blood

457

2303

2.16

45.22

7.2

6.1

11.2

12.3

kpa

4.18

430

2175

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

456

2304

2.16

44.79

7.2

6.1

5.1

kpa

0.37

429

2179

(3021901) Oxygen saturation in Capillary blood

121

297

4.21

44.59

3.4

2.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

369

1716

2.31

44.37

8.2

5.7

1.3

1.4

mmol/l

2.22

347

1633

(3013115) Eosinophils [#/volume] in Blood

1507

11164

1.71

43.98

8.4

5.4

0.2

e9/l

0.23

1342

9718

(3003396) Base excess in Arterial blood by calculation

453

2299

2.15

43.94

7.3

6.1

1.1

1.2

mmol/l

0.14

356

1757

(3026493) Urate [Moles/volume] in Serum or Plasma

847

5337

1.82

43.66

3.6

2.3

2112.4

6285.3

umol/l

3.69

712

4535

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

104

231

4.63

43.53

5.1

2.4

168.4

1186.2

u/ml

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1682

12864

1.71

43.41

7.3

4.0

7.2

6.7

mmol/l

11.83

1604

11938

(3049717) Cytology report of Urine Cyto stain

202

709

2.98

43.04

3.0

2.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1186

8359

1.70

40.58

7.3

3.6

—

(3016502) Oxygen saturation in Arterial blood

406

2042

2.15

40.08

7.4

6.5

94.4

95.7

2.30

391

1963

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2072

16962

1.74

40.00

10.7

6.5

85.1

77.9

u/l

6.25

1962

15797

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

897

5912

1.74

38.81

2.7

2.1

3.4

3.0

mg/l

3.93

776

4959

(42870588) Differential panel, method unspecified - Blood

1038

7138

1.70

38.38

7.7

5.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

965

6539

1.71

37.49

2.5

2.1

179.7

214.0

u/l

0.73

912

6092

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

261

1119

2.46

37.47

8.8

6.3

24.5

25.1

mmol/l

1.59

254

1114

(3018677) aPTT in Platelet poor plasma by Coagulation assay

553

3178

1.91

37.41

2.6

1.9

30.1

29.7

0.58

534

3063

(3027945) Reticulocytes/100 erythrocytes in Blood

455

2451

2.01

37.17

3.1

2.3

1.9

1.8

2.33

390

2119

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1182

8490

1.65

36.53

5.1

3.6

41.3

58.7

ng/l

0.95

847

5800

(3009508) Creatinine [Moles/volume] in Urine

939

6359

1.70

36.32

4.4

2.9

6.5

7.3

mmol/l

8.87

801

5264

(3020682) Albumin/Creatinine [Ratio] in Urine

928

6297

1.69

35.46

5.4

3.6

19.9

5.5

mg/mmol

10.09

695

3818

(3020630) Protein [Mass/volume] in Serum or Plasma

336

1654

2.16

34.80

2.8

2.4

65.5

66.6

g/l

1.45

301

1488

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

202

4.41

34.47

5.5

6.7

13.1

11.6

mg/l

1.48

188

(3012516) Albumin [Mass/volume] in Urine

882

5967

1.68

33.76

4.5

2.9

541.9

257.1

mg/l

1.06

671

3623

(3041096) Erythrocytes [Presence] in Urine by Automated

858

5779

1.68

33.31

6.3

3.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

941

6549

1.64

31.89

3.3

2.9

2407.5

1331.8

ng/l

6.15

798

5581

(3019309) Folate [Moles/volume] in Red Blood Cells

692

4446

1.73

31.76

2.0

1.7

1193.5

1163.8

nmol/l

0.33

530

3289

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

959

6744

1.62

30.98

4.0

2.9

32.5

32.0

u/l

0.13

907

6369

(3029937) Albumin [Presence] in Urine by Test strip

856

5853

1.65

30.93

7.9

3.7

0.0

estimate

0.02

300

1903

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

202

841

2.50

30.79

1.8

1.6

1.5

g/l

1.76

171

704

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1306

9895

1.57

30.69

3.9

2.6

134.5

109.7

ug/l

2.70

1212

9038

(3044640) Blood type and Crossmatch panel - Blood

987

7007

1.61

30.58

3.2

2.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

411

2277

1.94

30.58

3.3

4.1

235.6

243.5

u/l

0.51

379

2126

(3002173) Hemoglobin [Mass/volume] in Arterial blood

356

1891

2.00

29.89

8.0

6.8

117.5

121.5

g/l

3.47

347

1814

(40760888) Immunoglobulin light chains.free panel - Serum

123

400

3.17

29.85

3.6

3.2

—

(3024928) Oxygen saturation in Venous blood

113

352

3.30

29.43

4.0

2.8

—

(40767503) Oxygen content in Capillary blood by calculation

116

368

3.24

29.33

3.4

1.9

15.8

16.2

0.44

154

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

132

454

3.00

29.10

1.7

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

132

454

3.00

29.10

1.7

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

108

330

3.36

29.01

2.3

2.4

31.0

33.8

umol/l

0.76

278

(3052851) Hemolysis interference index of Serum or Plasma

164

637

2.67

28.81

4.3

3.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

759

5153

1.64

27.69

6.5

3.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

296

3.43

27.52

6.4

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

141

523

2.78

27.08

2.2

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

141

526

2.76

26.79

3.8

3.0

34.1

1.5

ratio

0.52

(3034860) Kappa light chains.free [Mass/volume] in Serum

144

544

2.73

26.71

3.8

3.0

91.4

36.3

mg/l

2.57

110

450

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

143

543

2.72

26.26

3.8

3.0

53.0

48.6

mg/l

0.11

109

452

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

387

2204

1.87

26.24

5.2

3.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

271

1368

2.08

26.05

2.7

2.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

344

1899

1.92

25.64

2.4

2.1

0.2

g/l

1.47

313

1762

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1194

9128

1.52

25.40

2.9

2.1

76.5

77.8

nmol/l

0.85

1078

8062

(3033658) Prothrombin time (PT) actual/Normal

773

5371

1.59

25.26

6.1

3.4

89.4

88.7

0.27

749

5222

(3004119) Hemoglobin [Mass/volume] in Venous blood

245

1212

2.11

24.82

5.2

2.6

121.8

129.9

g/l

6.57

239

1186

(3022217) INR in Platelet poor plasma by Coagulation assay

491

3060

1.73

24.47

28.6

26.7

1.5

1.4

inr

0.65

417

(3009445) Proteinase 3 Ab [Units/volume] in Serum

174

754

2.39

24.27

1.6

1.4

7.2

9.6

u/ml

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

694

4749

1.60

24.00

2.0

1.7

1.2

mg/l

0.08

541

3565

(3010421) pH of Blood

127

477

2.74

23.83

6.4

3.0

7.4

0.48

105

391

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

324

3.13

23.80

1.5

1.2

260.7

264.2

u/ml

0.03

174

(3022313) Gas panel - Capillary blood

190

863

2.28

23.79

5.8

2.7

—

(40758558) Short blood count panel - Blood

779

5488

1.57

23.75

9.8

6.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

119

433

2.82

23.71

2.9

1.9

125.2

128.9

g/l

0.76

295

(3019150) Specific gravity of Urine by Refractometry

708

4880

1.59

23.71

7.4

3.9

1.0

kg/l

0.48

124

737

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

103

346

3.05

23.69

1.4

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

5.35

23.25

1.3

1.1

—

(3024471) HLA-A [Type]

9.11

22.96

1.0

—

(3024932) HLA-DR beta [Type]

9.11

22.96

1.1

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

+∞

22.94

10.7

0.0

4.8

—

mmol/l

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

213

1032

2.15

22.75

10.1

7.8

24.3

24.5

mmol/l

0.53

197

943

(3017143) Hepatitis C virus Ab [Presence] in Serum

364

2129

1.81

22.48

2.0

1.4

—

(3012501) Base excess in Blood by calculation

110

395

2.85

22.47

6.2

3.2

2.7

2.6

mmol/l

0.09

260

(3023520) Reticulocytes [#/volume] in Blood

316

1769

1.88

22.46

3.2

2.3

73.1

69.5

e9/l

0.89

221

1351

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

155

662

2.42

22.33

2.3

2.1

683.2

385.7

ug/l

0.61

147

610

(3025941) Bacteria identified in Stool by Culture

231

1168

2.06

22.04

1.3

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

118

445

2.72

21.98

1.7

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

336

2.98

21.76

2.1

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

203

984

2.14

21.65

5.7

2.5

24.8

25.6

mmol/l

2.11

195

954

(3005719) IgG [Mass/volume] in Serum or Plasma

267

1440

1.94

21.22

3.1

2.6

11.0

10.6

g/l

0.31

253

1294

(3037756) Immunofixation for Serum or Plasma

111

414

2.75

21.13

1.6

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

342

2.93

21.10

2.1

1.2

—

22.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

114

432

2.70

21.05

1.8

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

245

1287

1.99

21.01

6.2

6.1

24.7

mmol/l

0.01

232

1195

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1301

10397

1.45

20.80

5.3

3.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

134

559

2.46

20.33

1.5

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

742

5326

1.52

20.27

3.1

2.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.63

19.95

1.0

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

383

2353

1.72

19.83

3.4

2.5

7.1

8.3

umol/l

0.85

321

2026

(3036481) Cortisol [Moles/volume] in Serum or Plasma

321

1878

1.80

19.70

2.3

2.0

358.1

379.8

nmol/l

1.21

291

1688

(3019060) Gas panel - Arterial blood

247

1331

1.93

19.65

4.3

4.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1648

13843

1.43

19.61

3.9

2.9

65.4

45.4

u/l

7.37

1558

12767

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.78

19.55

1.0

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

217

1128

2.00

19.16

2.2

1.7

1.3

1.5

g/l

0.74

204

1013

(3009466) Valproate [Moles/volume] in Serum or Plasma

284

3.01

19.15

4.8

4.3

354.4

351.8

umol/l

0.06

239

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1188

9441

1.43

19.04

2.3

2.0

92.0

94.9

pmol/l

1.37

681

4800

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

302

2.94

18.94

2.2

1.2

104.1

124.7

u/ml

0.69

(3015377) Calcium [Moles/volume] in Serum or Plasma

986

7588

1.45

18.73

3.8

3.0

2.3

2.4

mmol/l

7.61

869

6526

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

193

3.42

18.35

1.9

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

201

1033

2.01

18.32

9.2

8.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

322

1926

1.75

18.28

2.8

2.4

6.3

6.5

ug/l

0.06

270

1633

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

300

1779

1.76

17.53

6.8

2.8

1.2

mmol/l

1.30

261

1500

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.80

17.41

2.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

246

3.06

17.40

1.8

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

291

1716

1.77

17.33

4.8

4.0

1.0

0.9

0.14

107

442

(46235355) HIV 1 and 2 tests - Meaningful Use set

530

3648

1.55

17.21

2.2

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

122

527

2.37

17.17

1.7

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

310

2.79

16.93

1.9

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

267

1551

1.79

16.72

4.5

3.8

0.8

0.7

0.29

312

(3013707) Erythrocyte sedimentation rate by Westergren method

1884

16439

1.40

16.62

5.3

3.8

18.2

12.1

mm/h

30.77

1744

15119

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

232

1294

1.86

16.58

2.0

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

171

3.44

16.58

1.4

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

242

1368

1.84

16.57

1.6

1.4

—

(3000494) Fungus identified in Specimen by Culture

378

2429

1.64

16.36

1.6

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

315

1932

1.71

16.29

3.6

2.2

37.7

38.5

u/l

0.06

259

1614

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2429

22261

1.51

16.01

31.5

12.7

30.4

23.1

mg/l

19.80

2204

17532

(3021589) Normoblasts [#/volume] in Blood

1179

9563

1.39

15.92

16.1

8.5

0.0

e9/l

0.33

959

7802

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

305

2.74

15.76

1.7

1.4

—

(3037121) Protein [Mass/volume] in Urine

141

674

2.15

15.60

3.9

2.7

0.4

0.2

g/l

1.88

233

(3040151) Glucose [Moles/volume] in Capillary blood

227

3.00

15.28

9.4

6.4

7.8

7.6

mmol/l

0.08

189

(3021440) Promyelocytes/100 leukocytes in Blood

273

1639

1.73

15.23

4.9

4.0

0.1

0.50

101

403

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

162

830

2.01

14.90

4.9

4.4

1.8

1.6

0.73

154

776

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

172

901

1.97

14.86

2.3

1.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

106

462

2.34

14.66

1.7

1.2

20.3

8.3

iu/ml

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

160

821

2.00

14.66

4.9

4.4

0.8

0.9

1.25

151

768

(3014148) Varicella zoster virus Ab [Titer] in Serum

208

3.02

14.40

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

441

3030

1.54

14.23

2.0

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

134

3.55

14.17

1.6

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

179

3.17

14.12

1.3

1.1

61.2

57.8

u/l

0.12

122

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

238

2.86

14.07

1.7

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

636

4730

1.44

13.78

6.0

4.0

—

(3037522) Nuclear Ab [Titer] in Serum

401

2732

1.54

13.40

1.4

1.3

466.1

561.0

titre

0.75

585

(3024891) Influenza virus A+B Ag [Presence] in Specimen

118

559

2.16

13.39

1.4

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

146

753

1.99

13.20

6.6

2.8

24.6

25.1

mmol/l

1.09

134

687

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

155

818

1.94

13.12

2.1

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

579

4268

1.44

13.09

5.0

3.6

209.3

369.3

ng/l

1.41

471

3315

(40761535) Cells panel - Urine sediment

287

1817

1.64

13.09

5.8

3.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

703

5367

1.41

13.06

1.7

1.5

20.5

nmol/l

0.01

630

4525

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

330

2165

1.59

13.00

1.9

1.7

1.5

1.4

1.61

278

1889

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

583

4312

1.44

12.92

3.2

2.8

2.5

mmol/l

2.09

494

3760

(3044242) Glucose [Moles/volume] in Arterial blood

100

3.84

12.88

1.8

2.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

554

4062

1.45

12.86

1.7

1.4

2.5

2.4

g/l

0.41

348

2406

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

228

2.80

12.81

1.1

—

(3051651) Icteric interference index of Serum or Plasma

115

3.60

12.69

6.2

3.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

150

3.24

12.59

1.9

2.0

—

(3025159) Blasts/100 leukocytes in Blood

249

1543

1.67

12.33

5.1

4.0

0.0

0.4

0.75

337

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

261

1642

1.65

12.19

4.5

2.5

55.6

68.7

ml/min/173m2

5.60

146

666

(3022621) pH of Urine by Test strip

249

1550

1.66

12.12

4.5

2.9

—

(3016750) Collection duration of Urine

3.74

11.83

3.0

1.8

507.3

500.7

min

0.11

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

295

1932

1.59

11.68

3.4

2.8

263.6

209.6

ng/l

0.98

271

1733

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

467

2.16

11.40

3.3

2.2

143.1

59.7

ug/min

1.14

275

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

642

4925

1.39

11.39

1.9

1.7

40601925.1

25204687.1

pmol/l

0.21

532

4039

(3017569) Oxygen content in Arterial blood

3.87

11.36

1.8

2.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

267

2.54

11.32

1.5

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

107

3.49

10.98

1.2

106.8

80.1

u/l

0.92

(42529406) Shigella sp [Presence] in Stool by Culture

125

656

1.95

10.80

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

115

587

2.00

10.76

2.5

2.1

90.5

90.9

0.05

109

550

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

123

648

1.94

10.52

1.3

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

265

2.49

10.50

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

123

649

1.93

10.47

1.3

1.1

—

(3045716) Anion gap in Serum or Plasma

101

3.49

10.43

2.5

1.7

8.4

9.3

mmol/l

0.70

(3004775) Volume in Urine collected for unspecified duration

131

3.16

10.42

2.8

2.1

637.0

555.4

0.89

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

+∞

10.42

3.3

0.0

—

(40761536) Microorganisms panel - Urine sediment

275

1825

1.56

10.27

8.0

3.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

109

559

1.99

10.08

3.0

2.2

3.8

3.5

g/l

1.03

102

524

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

178

2.78

9.97

1.1

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

107

548

1.99

9.94

3.0

2.3

209.9

180.2

2.78

102

520

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

123

662

1.90

9.88

2.8

2.1

0.9

1.0

g/l

0.18

102

572

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

294

2.34

9.69

1.3

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

102

3.36

9.58

1.3

1.2

40.4

17.7

u/l

1.00

(3007566) Smooth muscle Ab [Titer] in Serum

494

2.02

9.53

1.3

1.2

77.8

92.1

titre

—

(3003181) Sodium [Moles/volume] in Urine

374

2.17

9.48

1.4

1.3

58.3

65.6

mmol/l

1.02

306

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

730

1.83

9.46

2.7

2.1

3.0

3.1

g/l

0.19

576

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

362

2.19

9.42

1.6

—

(3036489) Thrombin time

135

761

1.81

9.39

2.4

1.9

21.6

21.2

0.48

121

670

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

+∞

9.38

3.4

0.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

312

2.27

9.32

1.4

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

104

3.30

9.30

1.6

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

781

1.79

9.19

2.7

2.0

7.5

7.3

g/l

0.60

100

589

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

781

1.79

9.19

2.7

2.0

3.7

3.8

g/l

0.20

561

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

781

1.79

9.19

2.7

2.0

—

(3044290) Cell count panel - Cerebral spinal fluid

401

2.10

9.06

1.4

—

(40768797) Stomach Pathology biopsy report

398

2919

1.42

9.02

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

194

2.60

8.99

2.2

2.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2429

22838

1.36

8.97

33.0

14.6

139.1

139.6

mmol/l

16.51

2365

22167

(3017704) Immunofixation for Urine

3.39

8.89

1.2

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

123

3.03

8.85

1.3

—

(3012441) Differential panel - Pleural fluid

196

2.58

8.81

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1527

13547

1.26

8.81

3.4

3.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2432

22891

1.35

8.75

33.4

14.7

4.0

mmol/l

8.76

2366

22179

(3047181) Lactate [Moles/volume] in Blood

114

626

1.85

8.65

5.0

5.2

1.1

1.3

mmol/l

1.22

548

(3003434) Protein [Mass/volume] in Pleural fluid

265

2.33

8.64

1.5

1.4

30.4

32.0

g/l

0.52

237

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

492

1.96

8.60

1.4

1.3

581.1

507.0

mg/l

0.74

469

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

115

3.07

8.54

2.8

1.5

1.9

2.2

u/field

0.15

(3019977) pH of Arterial blood

100

3.22

8.48

2.1

2.8

7.4

0.42

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

352

2.13

8.44

1.3

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

189

2.57

8.40

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.25

8.34

1.1

—

(44790049)

214

2.46

8.31

1.8

1.5

—

(44790047)

214

2.46

8.31

1.8

1.5

—

(44806118)

214

2.46

8.31

1.8

1.5

—

(44790048)

214

2.46

8.31

1.8

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

439

1.99

8.13

1.4

169.7

24.3

e6/l

0.54

342

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

439

1.99

8.13

1.5

41020.9

1153.3

e6/l

0.49

362

(3043409) Potassium [Moles/volume] in Arterial blood

114

639

1.82

8.12

4.0

3.8

3.9

mmol/l

0.54

101

602

(3048689) Calprotectin [Mass/mass] in Stool

348

2540

1.42

8.08

2.6

2.2

163.5

122.8

ug/g

1.51

269

1968

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

599

4782

1.32

7.86

1.3

1.5

u/ml

0.02

157

1256

(3004809) Band form neutrophils/100 leukocytes in Blood

303

2.17

7.82

2.7

3.7

1.9

2.0

0.06

223

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.32

7.79

1.5

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

122

2.89

7.74

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

126

739

1.74

7.71

3.0

3.2

705.9

5776.9

u/ml

0.73

112

619

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

124

724

1.74

7.71

2.8

2.1

10.8

10.3

g/l

0.57

100

617

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

168

2.58

7.67

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.21

7.66

1.7

1.3

—

(3020891) Body temperature

138

833

1.69

7.62

6.1

4.0

—

(4035726)

263

1847

1.47

7.51

1.4

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

+∞

7.29

11.0

0.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

436

1.93

7.26

1.3

4.1

3.8

mmol/l

1.64

408

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

103

580

1.80

7.26

2.6

2.0

0.0

g/l

0.74

533

(3051611) Lipemic interference index of Serum or Plasma

222

2.32

7.25

6.2

3.2

—

(3011648) Oxygen content in Venous blood

139

2.68

7.15

3.7

3.4

11.2

10.8

0.23

139

(3030905) Polymorphonuclear cells [#/volume] in Blood

360

2.00

6.89

3.6

3.2

4.5

4.2

e9/l

0.52

360

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

228

2.26

6.83

1.5

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.11

6.81

1.2

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

249

2.19

6.73

1.5

1.4

1998.8

1865.7

e6/l

0.09

184

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

133

824

1.64

6.68

2.0

1.9

35.8

39.3

u/l

1.28

116

732

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

116

2.78

6.63

1.9

1.6

10.6

7.3

u/l

0.30

(3033799) Differential panel - Peritoneal fluid

4.02

6.62

1.4

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

106

2.85

6.52

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

106

2.85

6.52

1.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

102

594

1.74

6.46

1.4

267.2

285.5

ug/g

0.35

343

(3024980) IgG subclass 4 [Mass/volume] in Serum

280

2.09

6.45

1.5

1.6

0.5

0.8

g/l

1.46

214

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

370

1.94

6.40

4.0

3.5

60.1

57.7

0.92

370

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

167

2.41

6.28

1.1

1.5

22.5

21.9

u/ml

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

114

2.74

6.27

1.3

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.95

6.26

1.7

1.3

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

+∞

6.25

6.5

0.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

465

3697

1.31

6.18

1.3

52.6

34.3

iu/ml

0.96

153

1134

(3002385) Erythrocyte distribution width [Ratio]

1970

18323

1.23

6.17

33.3

15.6

14.1

13.7

18.06

1933

17854

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

450

1.82

6.03

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

3.17

6.01

1.5

—

(3044889) 12 lead EKG panel

1670

15300

1.21

6.01

4.3

3.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

5.23

6.00

3.7

2.0

0.8

u/field

0.08

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

300

2252

1.37

5.89

3.7

3.8

27.4

20.2

ug/l

0.20

248

1855

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

204

2.22

5.88

1.6

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

187

2.26

5.74

3.0

3.5

59.0

55.9

0.29

117

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

415

1.83

5.68

2.0

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

221

2.14

5.63

1.5

1.4

30890.0

61787.3

e6/l

0.52

138

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

475

1.77

5.63

1.7

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

345

1.90

5.60

1.6

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

164

2.33

5.58

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

164

2.33

5.58

1.2

1.4

1.6

1.5

nmol/l

0.17

141

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

101

613

1.67

5.55

2.6

1.9

36.1

38.1

g/l

1.92

526

(3016038) Potassium [Moles/volume] in Urine

140

2.45

5.53

1.4

1.1

26.3

35.3

mmol/l

2.35

126

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

109

676

1.64

5.51

2.9

2.7

—

(3017732) Neutrophils [#/volume] in Blood

208

1486

1.43

5.47

3.1

2.7

4.4

4.1

e9/l

0.84

164

1132

(3013512) EKG study

750

6400

1.23

5.44

4.8

3.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

205

2.16

5.41

3.1

2.2

—

(3044927) Protein electrophoresis panel - Urine

194

2.18

5.28

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

188

2.20

5.25

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1864

17363

1.20

5.24

4.4

4.0

14.7

14.8

pmol/l

1.58

1696

15703

(3003327) Ova and parasites identified in Stool by Light microscopy

108

678

1.62

5.22

1.7

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

+∞

5.21

4.4

0.0

19.2

—

mmol/l

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

+∞

5.21

4.4

0.0

518.0

—

umol/l

—

(3036525) Urea [Moles/time] in 24 hour Urine

+∞

5.21

3.8

0.0

—

(40757373) Influenza virus identified in Isolate

3.65

5.20

2.4

1.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.35

5.16

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.35

5.16

2.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

307

2363

1.33

5.13

2.2

2.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

115

2.54

5.12

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2118

19984

1.21

5.12

7.4

5.5

42.2

39.6

mmol/mol

18.78

1961

18297

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

279

2122

1.35

5.05

2.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.77

5.04

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.77

5.04

1.4

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

121

789

1.56

5.00

1.2

1.3

0.3

1.0

u/ml

1.24

(4024509)

206

2.10

4.96

1.3

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

187

2.15

4.91

1.5

1.4

7.9

6.3

mmol/l

1.95

172

(3020191) Ethanol [Moles/volume] in Serum or Plasma

136

2.37

4.90

1.4

1.3

1.8

1.2

promille

1.14

106

(3004716) Salmonella sp identified in Stool by Organism specific culture

162

1129

1.46

4.89

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

108

690

1.59

4.88

2.3

1.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

290

1.91

4.88

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

106

2.56

4.88

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

608

1.62

4.75

1.6

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

157

2.24

4.75

2.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

2.68

4.74

1.3

1.1

72.7

91.4

u/l

0.58

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

601

1.62

4.73

1.7

1.6

0.0

9.9

iu/ml

0.51

124

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

547

1.65

4.72

2.8

2.0

0.0

g/l

0.00

503

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

541

1.65

4.66

2.8

2.0

0.0

g/l

0.00

502

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.65

4.65

1.3

1.1

18.4

28.4

u/l

0.67

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.70

4.64

2.4

2.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

134

2.33

4.59

2.7

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.41

4.56

1.7

1.2

155.4

85.4

ng/l

1.17

(4062490)

167

2.17

4.52

1.2

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

432

3536

1.26

4.52

1.3

12.7

13.1

u/ml

0.03

164

1381

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

186

1352

1.40

4.48

2.8

3.2

4.3

4.5

pmol/l

0.95

168

1182

(3039000) Anion gap in Blood

441

1.70

4.43

6.1

5.9

10.9

11.2

mmol/l

0.40

393

(3045414) Leukocytes [Presence] in Urine

141

977

1.47

4.41

2.8

1.8

—

(3018572) Chloride [Moles/volume] in Blood

442

1.69

4.39

6.1

5.9

105.2

105.5

mmol/l

0.16

394

(3000330) Specific gravity of Urine by Test strip

166

1188

1.42

4.37

6.1

3.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

163

2.16

4.37

1.2

1.3

3.0

2.8

g/l

0.19

114

(3024139) IgG subclass 3 [Mass/volume] in Serum

163

2.16

4.37

1.2

1.3

0.5

0.4

g/l

0.77

112

(3051387) C reactive protein [Mass/volume] in Capillary blood

529

1.62

4.32

6.1

3.3

31.9

26.1

mg/l

0.67

351

(3027135) IgG subclass 1 [Mass/volume] in Serum

164

2.15

4.31

1.2

1.3

9.6

6.6

g/l

1.61

115

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.56

4.30

1.1

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

8.91

4.28

6.4

3.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

212

2.00

4.26

2.8

4.0

—

(40768806) Pleura Pathology biopsy report

207

1.99

4.16

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

249

1.90

4.16

1.1

1.6

1.5

g/l

0.80

226

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2438

23464

1.22

4.14

14.6

9.5

25.5

24.6

u/l

0.54

2358

22486

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

167

2.11

4.13

2.1

1.4

33.4

33.5

0.00

102

(3033705) Calcium.ionized [Moles/volume] in Venous blood

286

1.83

4.11

3.5

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

287

1.83

4.07

3.7

2.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

223

1.94

4.06

2.0

1.5

57.5

57.0

0.02

135

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

548

1.59

3.99

1.5

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.44

3.96

2.2

2.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.82

3.95

1.4

8.4

101.3

66.1

mg/l

0.37

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

511

1.60

3.93

2.0

12.3

10.3

mg/l

0.81

466

(3014271) Vancomycin [Susceptibility]

125

2.25

3.89

3.5

3.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

489

1.61

3.88

1.6

19536.9

12612.2

e6/l

0.68

355

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.69

3.82

1.1

1451.8

1598.3

miu/ml

0.21

(3052592) Norovirus Ag [Presence] in Stool

3.19

3.77

1.6

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2153

20540

1.18

3.77

25.8

11.9

74.3

80.5

ml/min/173m2

21.06

1841

16817

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

12.02

3.76

2.3

5.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

209

1.93

3.72

2.8

2.0

3.3

2.2

u/field

0.55

(3035637) Corticotropin [Mass/volume] in Plasma

225

1.88

3.64

1.7

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.61

3.63

1.4

74.9

60.8

1.00

(3023511) Choriogonadotropin [Units/volume] in Urine

460

1.60

3.59

1.7

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

117

2.23

3.57

2.0

2.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.66

3.56

1.3

1.6

87.0

93.7

umol/l

—

(3025549) Creatine [Moles/time] in 24 hour Urine

7.79

3.56

1.1

1.4

—

(36660697) Celiac disease serology panel - Serum

216

1671

1.32

3.54

1.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

199

1.92

3.53

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

10.02

3.49

1.3

1.0

4.0

4.5

mmol/l

—

(40761511) CBC panel - Blood by Automated count

2394

23095

1.19

3.46

25.6

12.3

—

(3011288) Drugs identified in Urine by Screen method

459

1.58

3.39

4.3

2.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

121

2.16

3.32

3.0

1.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

169

1.96

3.28

1.2

1.4

13.5

11.2

mmol/l

—

(3019225) pH of Specimen

277

2237

1.26

3.27

7.7

3.4

—

(3045424) Erythrocytes [Presence] in Urine

331

1.67

3.26

2.0

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.30

3.26

2.0

3.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

6.38

3.18

7.0

3.5

17.7

16.4

mg/l

—

(3035880) pH of Pleural fluid

111

2.17

3.12

1.4

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.51

3.11

3.3

2.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

518

1.52

3.10

3.9

3.1

0.9

0.8

nmol/l

1.13

399

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

283

1.71

3.09

1.4

1.2

3.8

5.4

u/ml

0.54

112

(40768804) Tissue Pathology biopsy report

995

9065

1.15

3.07

2.3

2.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

634

1.47

3.06

1.9

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.69

3.05

1.2

1.8

864.8

827.5

e6/l

—

(4198724)

2.69

3.05

1.5

1.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

7.51

3.05

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

254

1.74

3.05

1.5

1.3

—

(3004451) EKG impression Narrative

2.27

3.03

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

820

0.62

3.03

1.5

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

10.01

2.98

1.8

1.2

572.8

492.8

umol/24h

—

(3023410) Appearance of Cerebral spinal fluid

197

1.84

2.98

1.5

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.24

2.96

2.1

2.0

108.4

100.7

0.32

(3028433) Virus identified in Specimen by Culture

2.55

2.95

1.1

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

169

1.90

2.95

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

169

1.90

2.95

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

169

1.90

2.95

1.7

1.6

—

(3045788) Cell count panel - Pleural fluid

198

1.83

2.93

1.7

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

191

1.84

2.92

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.33

2.91

2.4

1.3

1.8

4.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1157

0.68

2.90

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

617

1.46

2.89

7.6

3.9

—

(3005570) Glucose [Moles/volume] in Urine

236

1.75

2.88

2.5

2.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.70

2.88

1.2

—

(3042631) Mycobacterium sp identified in Specimen

274

1.69

2.87

2.2

2.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.26

2.86

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.93

2.85

1.3

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.93

2.85

1.4

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

291

1.66

2.81

1.5

1.2

2.8

3.4

u/ml

0.17

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

307

1.64

2.79

1.2

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

4.45

2.79

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.55

2.78

2.3

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

293

1.65

2.75

1.4

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.51

2.70

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.51

2.70

1.4

2.4

3.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

249

1.70

2.69

1.5

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

644

1.43

2.67

1.3

164.4

215.3

miu/ml

0.69

316

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

250

1.69

2.65

1.5

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1.94

2.65

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

140

1.94

2.65

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1.94

2.65

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1.94

2.65

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

140

1.94

2.65

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

2097

20157

1.14

2.64

28.5

14.2

38.0

39.0

5.17

1426

14146

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

129

1694

0.75

2.62

1.5

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.66

2.62

2.0

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

251

1.68

2.62

1.5

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

251

1.68

2.62

1.5

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

514

1.47

2.61

3.0

1.9

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

141

1.92

2.60

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

607

1.43

2.58

2.8

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.61

2.57

1.1

2.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

410

1.52

2.57

3.3

26.3

1002.7

u/ml

0.93

383

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

7.15

2.55

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.46

2.54

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.43

2.54

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

474

0.54

2.53

1.7

—

(4306422)

285

1.62

2.51

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

662

1.40

2.49

2.7

1.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2139

20616

1.14

2.48

5.4

4.8

1.9

2.1

mu/l

0.64

1963

18754

(3008295) Osmolality of Serum or Plasma

217

1.71

2.48

1.2

1.4

282.9

275.8

mosm/kgh2o

1.49

156

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

123

1.96

2.45

1.8

2.1

9.9

14.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.67

2.45

1.5

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

181

1.78

2.43

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

124

1.94

2.40

1.9

2.1

79.3

73.0

1.85

118

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

212

1.71

2.39

1.1

—

1.3

—

(3027944) Amphetamines [Presence] in Urine

659

1.39

2.38

2.7

1.8

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

6.26

2.37

1.0

21.1

22.1

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

6.26

2.37

1.0

9.0

8.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

6.26

2.37

1.0

34.9

38.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

146

1.86

2.37

1.5

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

118

1.96

2.35

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.15

2.34

1.4

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

110

825

1.35

2.33

2.2

2.1

3918.4

4453.6

u/l

0.10

326

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.22

2.30

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

105

2.01

2.30

1.1

1.4

1.1

1.3

nmol/l

0.18

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.38

2.29

2.6

1.4

—

(3027008) Opiates [Presence] in Urine

665

1.38

2.27

2.7

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.23

2.27

3.1

2.1

—

(3042517) Benzodiazepines panel - Urine

4.62

2.27

3.0

2.1

—

(3011412) CD3 cells [#/volume] in Blood

163

1.79

2.27

2.6

2.4

1.6

1.1

e9/l

0.45

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

185

1494

1.25

2.26

1.1

1.2

86.2

148.7

iu/ml

2.07

560

(3028300) Cannabinoids [Presence] in Urine

667

1.38

2.24

2.8

1.8

—

(3022145) Colonoscopy Study observation

269

2264

1.21

2.23

1.4

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.11

2.22

2.0

2.4

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

5.56

2.21

1.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

593

1.39

2.19

1.3

1.2

50.5

57.3

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.34

2.18

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.34

2.18

1.0

1.2

—

(3021788) Differential panel - Synovial fluid

361

1.51

2.17

1.8

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

101

1.99

2.15

1.6

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

101

1.99

2.15

1.6

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

101

1.99

2.15

1.6

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

101

1.99

2.15

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

153

1217

1.27

2.14

2.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.11

2.12

1.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.45

2.10

1.2

1.7

2409.8

3708.4

e6/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.71

2.10

7.9

6.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

174

1409

1.25

2.10

2.3

2.4

27.6

19.3

au/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

523

1.41

2.07

1.3

11.4

11.5

u/l

0.02

411

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.91

2.07

1.1

1.3

20.7

26.4

g/l

—

(4146454)

214

1.64

2.06

3.1

2.8

—

(3036603) Volume of Urine

117

1.89

2.06

1.7

1.4

2044.7

1990.0

—

(3010813) Leukocytes [#/volume] in Blood

2523

24674

1.15

2.04

40.1

19.2

7.3

6.7

e9/l

17.64

2453

23863

(3007461) Platelets [#/volume] in Blood

2521

24654

1.15

2.04

40.0

19.2

253.0

251.1

e9/l

0.67

2462

23921

(3024522) Salmonella sp identified in Specimen by Organism specific culture

254

1.58

2.03

1.5

1.3

—

(3024731) MCV [Entitic volume]

2522

24666

1.15

2.03

39.9

19.1

91.2

91.0

0.93

2479

24229

(3002256) Pathology report gross observation

330

2855

1.18

2.02

1.4

1.3

—

(3035941) MCH [Entitic mass]

2522

24668

1.15

2.02

39.8

19.1

30.1

30.3

2.56

2478

24230

(3026361) Erythrocytes [#/volume] in Blood

2522

24669

1.15

2.01

40.0

19.2

4.3

4.4

e12/l

36.05

2451

23858

(3013727) Leukocytes other/100 leukocytes in Blood

2.23

2.00

2.1

4.2

58.6

51.3

0.75

(3003338) MCHC [Mass/volume]

1948

18770

1.11

1.99

35.4

17.0

330.1

331.7

g/l

10.77

1920

18566

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

554

1.38

1.97

1.3

1.2

2.5

9.2

u/ml

1.60

(3000963) Hemoglobin [Mass/volume] in Blood

2522

24678

1.15

1.96

40.3

19.3

128.4

133.7

g/l

55.76

2481

24243

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

434

3845

1.15

1.95

1.6

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.97

1.93

2.1

2.6

—

(3017509) Phencyclidine [Presence] in Urine

3.76

1.93

1.0

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.76

1.93

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.73

1.93

6.3

6.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

113

1.86

1.91

1.3

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

135

1.78

1.91

1.1

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.25

1.90

1.8

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

228

1.59

1.87

3.0

3.2

—

(3023419) Bacteria identified in Sputum by Culture

276

1.53

1.87

2.2

2.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

366

1.46

1.86

3.4

1.6

1.0

0.8

nmol/l

1.21

303

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.03

1.85

1.7

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.03

1.85

1.7

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

536

1.37

1.83

3.4

2.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

137

1.76

1.83

1.1

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

343

1.47

1.82

1.4

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.17

1.82

1.4

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

3.85

1.71

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.14

1.71

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

650

5961

1.12

1.70

4.8

5.3

4.8

3.3

ug/l

0.97

577

5240

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.19

1.67

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

104

1.83

1.67

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

284

1.49

1.67

1.2

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.16

1.66

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.16

1.66

1.0

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

301

1.47

1.65

1.0

1.1

2191.8

iu/ml

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

165

1.64

1.2

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

547

1.34

1.64

1.3

1.2

6.6

3.1

u/ml

0.61

(3006653) Thiamine [Moles/volume] in Blood

1.84

1.61

1.6

1.2

156.9

135.3

nmol/l

0.61

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.15

1.61

1.0

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

107

849

1.27

1.60

1.1

6.3

1.1

u/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

167

1.62

1.58

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

240

2074

1.17

1.54

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

100

1.80

1.53

3.4

3.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

515

0.68

1.52

1.5

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.34

1.52

2.8

5.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

426

1.37

1.50

1.3

1.2

2.7

1.8

u/ml

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

130

1064

1.23

1.50

1.3

1.4

28.0

27.4

iu/l

0.06

106

901

(3000012) Reticulocyte production index

101

1.79

1.48

1.3

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.23

1.46

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.23

1.46

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.23

1.46

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.23

1.46

1.3

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.13

1.44

1.0

—

(44806071)

2.73

1.43

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

2.73

1.43

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.04

1.43

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

766

1.26

1.40

1.5

1.6

272.9

294.8

mu/l

0.39

685

(3004616) Nuclear Ab [Presence] in Serum

263

1.45

1.39

1.4

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.61

1.36

1.0

—

(21494755) Public health laboratory ask at order entry panel

150

1776

0.84

1.35

1.3

—

(40768443) Skin Pathology biopsy report

113

924

1.23

1.34

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.10

1.30

1.3

1.1

—

(4268621)

193

1.51

1.29

2.7

2.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

401

0.67

1.27

1.6

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

336

1.37

1.27

1.1

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

302

1.40

1.27

2.1

2.2

25.4

24.3

mg/l

0.03

(40768800) Prostate Pathology biopsy report

375

0.66

1.24

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.40

1.24

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

100

1.70

1.23

2.6

1.2

15.2

27.1

umol/l

1.91

(3024263) Appearance of Synovial fluid

100

1.70

1.23

1.5

1.6

—

(4212803)

2.63

1.21

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

132

1.60

1.20

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

569

1.27

1.18

1.3

—

(1002224) Polysomnography panel

732

1.24

1.16

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

129

0.46

1.16

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

519

4802

1.10

1.16

4.6

22.7

21.8

0.62

268

2425

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

742

0.78

1.12

1.4

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

100

828

1.21

1.10

1.7

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

442

1.30

1.09

1.2

35.5

40.7

u/ml

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.38

1.09

1.6

1.3

62.3

67.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.73

1.09

1.0

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

321

1.34

1.07

1.5

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

348

1.33

1.06

1.9

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.12

1.05

1.3

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.12

1.05

1.4

1.1

95.3

91.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

195

1.44

1.04

1.4

1.3

16961.9

175151.4

e6/l

1.60

132

(4094501)

544

1.26

1.04

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.64

1.03

1.0

—

(3014891) Appearance of Pleural fluid

2.06

1.03

2.1

1.4

—

(3015183) Erythrocyte sedimentation rate

107

0.47

1.01

1.4

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1124

0.83

1.00

1.8

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.00

1.00

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1100

0.83

0.99

1.6

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

140

1.50

0.97

1.0

1.2

—

(3044941) Cell count panel - Synovial fluid

319

1.32

0.96

1.5

1.4

—

(1761868) Lipid panel - Serum or Plasma

681

7203

0.93

0.95

3.1

2.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.69

0.95

1.1

1.2

—

(40768793) Breast Pathology biopsy report

557

0.77

0.95

1.4

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.78

0.94

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.22

0.93

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

243

1.36

0.92

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.67

0.91

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

244

1.36

0.90

1.1

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

247

2725

0.90

0.89

4.6

4.3

32.5

33.2

0.48

190

1781

(1617658) Protocol used for examination of sentinel lymph nodes

194

0.62

0.89

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.91

0.88

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.91

0.88

1.9

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.86

0.87

1.1

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

252

0.67

0.86

1.1

1.0

0.0

0.3

u/ml

—

(3002619) Bacteria identified in Specimen by Culture

1.82

0.85

1.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

541

1.22

0.85

1.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

239

1.34

0.84

1.7

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

121

1.49

0.82

2.6

2.4

567.7

696.4

e6/l

—

(3044007) Cell count panel - Peritoneal fluid

1.70

0.80

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

146

1289

1.14

0.80

1.3

260.7

202.2

u/ml

0.32

139

1186

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.82

0.79

2.7

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

156

1.41

0.78

1.6

1.7

—

(3022689) Creatine [Moles/volume] in Urine

1.67

0.78

2.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.53

0.78

1.2

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.53

0.78

1.2

1.4

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.76

0.0

1.2

—

4.5

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.09

0.74

4.0

3.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

161

1440

1.12

0.74

1.8

—

(3008898) HLA-B27 [Presence]

726

1.18

0.74

1.0

1.1

—

(3034426) Prothrombin time (PT)

1.64

0.73

1.1

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2169

21348

1.06

0.73

4.9

4.4

6.2

5.9

mmol/l

11.36

1966

19230

(3009871) Measles virus Ab [Titer] in Serum

1.67

0.72

1.6

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.67

0.72

1.1

1.3

—

(40768441) Liver Pathology biopsy report

143

1.40

0.70

1.6

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

126

1115

1.14

0.70

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.85

0.68

6.6

7.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.85

0.68

1.2

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.85

0.68

2.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

296

0.74

0.68

1.0

1.1

6.5

4.0

u/ml

—

109

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.55

0.67

1.0

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

367

3439

1.08

0.66

2.9

3.2

0.8

ug/l

0.36

257

2335

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.79

0.66

3.4

2.9

—

(3000492) Spirometry study

211

1931

1.10

0.66

1.6

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

111

1.44

0.65

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

120

1.42

0.64

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

270

1.26

0.62

1.1

1.3

0.6

nmol/l

0.07

257

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.61

1.0

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.67

0.61

1.4

1.9

78.8

42.2

umol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

545

1.18

0.61

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

122

1.40

0.60

1.1

1.5

1.1

u/l

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.56

0.58

1.9

2.5

6.1

10.4

—

(4281824)

219

1.28

0.58

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

604

1.16

0.58

1.1

5.0

7.3

u/ml

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.62

0.55

4.7

2.5

—

(21494434) Karyotype in Bone marrow

194

0.72

0.54

1.0

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

116

1.38

0.54

3.1

2.6

0.2

e9/l

0.00

105

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.47

0.54

1.2

1.1

—

(3048879) Bone marrow aspiration report

1.50

0.54

2.7

1.9

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.50

0.54

1.4

8.0

8.8

ug/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.54

0.53

1.3

1.8

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.54

0.53

1.0

1.2

—

68.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

295

1.22

0.52

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

271

0.77

0.52

1.0

1.1

5.0

5.7

u/ml

—

110

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.43

0.52

1.9

2.5

29.1

27.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

296

1.22

0.51

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.41

0.51

1.0

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

135

1.34

0.51

1.1

1.4

1.1

1.0

g/l

0.77

135

(3032773) Endomysium IgG Ab [Titer] in Serum

189

1.27

0.49

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

235

1.24

0.48

1.0

1.3

—

nmol/l

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

550

1.15

0.47

1.6

1.9

5.7

4.6

iu/l

0.24

196

(3003694) ABO and Rh group [Type] in Blood

629

6071

1.05

0.45

1.5

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

320

1.19

0.44

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

799

0.89

0.44

1.5

1.6

4.5

3.7

mg/l

0.24

559

(4034850)

756

0.88

0.43

19.6

10.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

163

0.74

0.43

1.3

1.6

8.0

7.6

mmol/l

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.41

0.43

1.1

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.61

0.43

1.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.61

0.43

1.0

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

1.1

—

(4211845)

131

1.30

0.42

6.6

3.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.36

0.41

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

11.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.47

0.40

1.6

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

1.43

0.39

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.31

0.35

2.3

1.9

—

(4027681)

127

1.26

0.33

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

186

1968

0.94

0.33

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.30

0.33

1.7

3.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.28

0.32

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

252

0.83

0.32

1.0

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.71

0.30

4.0

5.1

—

67.4

—

(3006462) Nitrate [Presence] in Urine

120

1.25

0.30

5.7

3.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

130

0.77

0.29

7.1

6.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

232

1.17

0.28

1.4

333.0

317.8

pmol/l

0.06

175

(3005082) Progesterone [Moles/volume] in Serum or Plasma

112

1.25

0.28

1.4

1.3

24.9

31.6

nmol/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.30

0.28

1.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.25

0.27

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.20

0.25

1.7

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

339

0.88

0.24

1.3

1.4

0.3

0.4

nmol/l

0.23

266

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

275

2847

0.96

0.23

15.4

6.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2055

20404

1.02

0.23

4.3

3.7

1.4

1.2

mmol/l

11.59

1879

18439

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.24

0.23

1.0

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.25

0.22

1.4

1.1

33.3

46.6

u/ml

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.22

0.22

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

191

1.15

0.21

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

252

0.87

0.21

1.5

1.8

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.8

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

12.9

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

5.9

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

118

1.19

0.19

1.0

1.4

—

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

120

1145

1.05

0.18

1.7

—

(3025130) Human papilloma virus identified in Specimen

290

0.90

0.18

2.2

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.21

0.18

4.6

2.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

157

1.15

0.17

1.2

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

272

1.10

0.17

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

576

0.94

0.16

1.5

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

328

0.91

0.15

1.3

1.4

27.2

26.4

u/l

0.05

270

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

244

2377

1.03

0.15

1.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.81

0.14

1.7

1.8

45.2

112.7

ug/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

131

1.15

0.14

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

118

0.85

0.14

1.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

578

0.95

0.11

1.5

1.4

—

(4010399)

147

1510

0.97

0.11

1.7

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

577

0.95

0.11

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

577

0.95

0.11

1.5

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.14

0.10

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

375

3802

0.98

0.09

1.4

—

(3020491) Glucose [Moles/volume] in Blood

176

0.91

0.09

1.7

2.3

6.8

6.6

mmol/l

—

115

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

625

0.96

0.09

1.5

—

(3045142) Bone marrow Pathology biopsy report

233

1.07

0.09

1.1

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.11

0.09

1.0

—

(4015189)

1.11

0.09

1.5

2.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

115

1179

0.97

0.08

2.5

2.0

9.9

11.7

nmol/l

1.62

1020

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

166

1.08

0.07

1.1

1.3

0.1

1.0

u/ml

—

(3051593) INR in Capillary blood by Coagulation assay

118

1.10

0.07

4.5

13.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

344

1.05

0.06

1.0

1.1

0.9

3.2

u/ml

—

(44813793)

148

1.08

0.06

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2133

21374

0.99

0.06

4.7

4.2

4.5

4.6

mmol/l

8.64

1978

19611

(3005033) Fetal Nuchal fold Thickness US

474

1.03

0.05

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

556

5522

1.01

0.05

1.8

1.6

1.5

1.3

mmol/l

3.93

459

4638

(3050129) First trimester maternal screen panel - Serum or Plasma

713

1.02

0.05

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

327

1.04

0.05

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

280

0.96

0.03

2.6

2.2

7.4

5.2

umol/l

0.39

193

(3008401) Mugwort IgE Ab [Units/volume] in Serum

349

0.97

0.02

1.1

0.5

1.3

u/ml

1.22

149

(3013139) Helicobacter pylori Ag [Presence] in Stool

146

1472

0.99

0.02

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

117

0.94

0.01

2.4

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2187

21883

1.00

0.01

5.1

4.7

2.6

2.7

mmol/l

13.53

2005

19944

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

246

0.98

0.00

1.1

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

404

1.02

0.00

1.2

1.1

1.2

1.9

u/ml

0.38

162

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2119

21195

1.00

0.00

4.6

4.2

1.4

1.5

mmol/l

18.22

1948

19296

(3003888) Timothy IgE Ab [Units/volume] in Serum

365

1.01

0.00

1.1

2.7

5.4

u/ml

1.19

188

(3045683) HLA typing for celiac disease panel - Blood or Tissue

125

1.04

0.00

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

476

1.01

0.00

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

303

0.99

0.00

1.2

1.1

4.3

2.4

u/ml

0.44

125

(3043238) Trisomy 21 risk [Likelihood] in Fetus

488

1.00

0.00

1.4

1.5

—

(3006270) Folate [Moles/volume] in Blood

215

0.98

0.00

1.0

1.2

376.3

355.4

nmol/l

0.11

184

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

148

1.01

0.00

1.3

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

106

1.04

0.00

1.4

1.2

2.8

4.8

umol/l

1.36

100

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

212

0.99

0.00

3.6

4.7

39.4

80.2

u/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.00

0.00

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

132

0.98

0.00

1.2

1.5

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.9

—

(40765096) Chromosome analysis panel by Banding

0.95

0.00

1.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.92

0.00

1.0

—

(44806420)

0.90

0.00

2.5

2.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

12.9

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.87

0.00

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.92

0.00

1.2

1.1

—

3.2

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_TUBULOINTNEPHRNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_TUBULOINTNEPHRNAS	2.393 [2.11, 2.71]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.126

During the follow-up period (1.1.1998 — 31.12.2019), 6559 out of 13875 females with N14_TUBULOINTNEPHRNAS died.

Males

Parameter	HR [95% CI]	p-value
N14_TUBULOINTNEPHRNAS	2.579 [2.22, 3.0]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 4318 out of 8081 males with N14_TUBULOINTNEPHRNAS died.

Mortality risk

Mortality risk for people of age

years, who have N14_TUBULOINTNEPHRNAS.

N-year risk	Females	Males
1	0.191%	0.453%
5	1.186%	2.861%
10	3.107%	7.734%
15	6.123%	14.366%
20	10.785%	24.075%

Relationships between endpoints

↥

Index endpoint: N14_TUBULOINTNEPHRNAS – Tubulo-interstitial nephritis, not specified as acute or chronic

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Tubulo-interstitial nephritis, not specified as acute or chronic

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints